Therapeutic Apheresis and Dialysis (journal)

published in (P1433)

Q87362281	"Palliative hemodialysis" in the context of end-of-life care for dialysis patients
Q87617985	"Streptococcus vestibularis": A Rare Cause of Peritoneal Dialysis-Related Peritonitis
Q82925104	'Takotsubo' cardiomyopathy in a maintenance hemodialysis patient
Q87083718	10th Congress of the International Society for Apheresis 13-16 May 2015 Cancún, Mexico
Q43076067	15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
Q81537195	18th annual meeting of the Japanese Society for Kidney Bone Diseases. Preface
Q46229570	19th Annual Meeting of the Japanese Society for Kidney Bone Disease
Q50776637	2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
Q56786844	2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis
Q45179903	2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease
Q82670466	2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis
Q44509098	2011 JSDT standard on the management of endotoxin retentive filter for dialysis and related therapies
Q42982450	2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients
Q56768480	2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis
Q54314411	24-hour performance of albumin dialysis assessed by a new two-compartment in vitro model.
Q51156396	30(th) Annual Meeting of the Japanese Society for Apheresis.
Q40312576	33 Years of Peritoneal Dialysis-Associated Peritonitis: A Single-Center Study in Japan.
Q51249847	34th annual meeting of the Japanese Society for Apheresis.
Q51289051	35(th) Annual Meeting of the Japanese Society for Apheresis.
Q73470798	3rd World Congress of the International Society for Apheresis (ISFA). January 11-14, 2001. Taipei, Taiwan. Abstracts
Q97535113	40th Annual Meeting of Japanese Society for Apheresis: Apheresis: The Progress Spreading Worldwide
Q50259385	50 classic illustrations of the beginnings of bloodletting and transfusion
Q91887352	A 24-Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients
Q59649474	A Case Report of Double Filtration Plasmapheresis in an Acute Episode of Multiple Sclerosis
Q60210037	A Case Study on Peritoneal Dialysis With Biocompatible Peritoneal Dialysis Fluid: Increase in Submesothelial Compact Zone Thickness But Not Vessel Density
Q91538246	A Case Where Selective Plasma Exchange for Neuromyelitis Optica Was Effective
Q87415970	A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc
Q98242848	A Case of Incarcerated Infected Tunneled Hemodialysis Catheter with Contamination of Transvenous Pacemaker Leads
Q98166590	A Case of Septic Pulmonary Embolism derived from Mitral Valve Endocarditis in a Patient with End-stage Kidney Disease at the initiation period of Hemodialysis
Q91593736	A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites
Q39512919	A Prospective Multicenter Randomized Controlled Study on Interleukin-6 Removal and Induction by a new Hemodialyzer With Improved Biocompatibility in Hemodialysis Patients: A Pilot Study
Q57477409	A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti-Platelet Activation Membrane Dialyzer in Hemodialysis Patients
Q91541184	A Solution Kinetics Simulation Method for Conventional and Selective Plasma Exchange Using a Complete Mixed Reactor Model
Q44101029	A Thought on Possible Pathogenesis of Ebola Viral Hemorrhagic Disease and Potential Treatments: Could it Be Thrombotic Thrombocytopenic Purpura-Like Syndrome?
Q51695700	A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation.
Q44530326	A case of advanced primary biliary cirrhosis treated with granulocyte and monocyte apheresis
Q80113974	A case of chronic relapsing ANCA-associated microscopic polyangiitis successfully treated with plasma exchange
Q102063979	A case of dialysis interruption caused by voluntary quarantine against the coronavirus disease (COVID-19) after returning from overseas to Japan
Q40497268	A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange
Q45864250	A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis
Q85046127	A case of hemodialysis-associated anaphylaxis or anaphylactoid reaction, which responded successfully to very gradual tapering dose of corticosteroid
Q44235200	A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis
Q88154852	A case of neuromyelitis optica spectrum disorder with early successful induction of double filtration plasmapheresis
Q46631815	A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis
Q33336453	A case of thrombotic thrombocytopenic purpura refractory to plasma exchange.
Q84871642	A case of tuberculous lymphadenitis in a dialysis patient with a negative QuantiFERON-TB Gold test
Q53452105	A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient.
Q46044457	A case report of a bone histomorphometrical analysis after a total parathyroidectomy
Q79797708	A case report of a diabetic nephropathy patient with cirrhotic ascites treated by peritoneal dialysis
Q40427654	A case report of a pyogenic liver abscess caused by Fusobacterium nucleatum in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis
Q84149176	A case report of a successful monochorionic diamniotic twin pregnancy in a patient affected by sickle cell disease treated with erythrocytapheresis
Q40213598	A case report of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient
Q52704830	A case report of acute renal failure associated with bee pollen contained in nutritional supplements.
Q46044475	A case report of amitriptyline poisoning successfully treated with the application of plasma exchange
Q46165020	A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis
Q46307210	A case report of an anorexia nervosa patient with end-stage renal disease due to pseudo Bartter's syndrome and Chinese herb nephropathy requiring maintenance hemodialysis
Q53680897	A case report of autoimmune pancreatitis accompanied with rapidly developing hyperglycemia and hypertension in a chronic hemodialysis patient.
Q47980189	A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervals
Q51663041	A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria.
Q46165021	A case report of double-filtration plasmapheresis for the treatment of age-related macular degeneration
Q40382002	A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome
Q79797704	A case report of hemodialysis intolerance with eosinophilia
Q81226579	A case report of hepatorenal syndrome treated with plasma diafiltration (selective plasma filtration with dialysis)
Q80697368	A case report of interferon beta monotherapy for high hepatitis C viral load in dialysis patients
Q79346594	A case report of leukocytapheresis for refractory leg ulcers complicated with rheumatoid arthritis
Q51765903	A case report of long-term remission of ulcerative colitis after lymphocyto-plasmapheresis.
Q40450062	A case report of neonatal onset multisystemic inflammatory disease in Japan treated with continuous hemodiafiltration and steroid pulse therapy.
Q46370569	A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis
Q47285064	A case report of osteomyelitis pubis in a hemodialysis patient with diabetes mellitus
Q81960840	A case report of pediatric fulminant hepatitis treated with plasma diafiltration
Q49126105	A case report of plasma exchange therapy in non-paraneoplastic cerebellar ataxia associated with anti-Yo antibody
Q45880982	A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors
Q80322576	A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis
Q48607236	A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody
Q79663860	A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis
Q52920358	A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
Q39225330	A case report of progressive multifocal leukoencephalopathy in a human T-cell lymphotropic virus type 1-infected hemodialytic patient
Q79346605	A case report of pulmonary-renal syndrome treated with continuous hemodiafiltration and hemodialysis
Q46665601	A case report of recurrent vascular access thrombosis in a hemodialysis patient reveals combined acquired and inherited thrombophilia
Q53487146	A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.
Q50605783	A case report of severe visceral beta2-microglobulin-derived amyloidosis without obvious joint symptoms or radiological findings in a chronic hemodialyzed patient with systemic lupus erythematosus.
Q84149170	A case report of spontaneous concurrent bilateral rupture of the quadriceps tendons in a patient with chronic renal failure
Q81226572	A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis
Q46044459	A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient
Q46044474	A case report of successful long-term relapse control by protein-a immunoadsorption in an immunosuppressive-treated patient with end-stage renal disease due to Wegener's granulomatosis
Q46370562	A case report of successful treatment with immunoadsorption onto protein A in mixed connective tissue disease in childhood
Q40391968	A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl
Q31120166	A case report of syndrome of inappropriate secretion of antidiuretic hormone with marked edema due to administration of hypertonic saline
Q33379740	A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura
Q46307213	A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy
Q51905547	A case report of the effect of acetate-free biofiltration on arrhythmia in a hemodialysis patient.
Q40516583	A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome
Q33360889	A case report of the efficacy of apheresis for refractory autoimmune thrombocytopenia in a patient with systemic lupus erythematosus associated hemolytic anemia
Q42978192	A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome
Q80025064	A case report of the therapeutic effect of cryofiltration in a patient with glucocorticoid-resistant ulcerative colitis
Q80025055	A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis
Q33389410	A case report of thrombocytopenia-associated multiple organ failure secondary to Salmonella enterica serotype Typhi infection in a pediatric patient: successful treatment with plasma exchange
Q33376615	A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis
Q33349565	A case report of total abdominal hysterectomy resulting in acute thrombotic thrombocytopenic purpura with pancreatitis and hepatitis: complete resolution with plasma exchange therapy
Q33378563	A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura
Q33378566	A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura
Q46665604	A case report on the role of plasma exchange in the management of a massive amlodipine besylate intoxication
Q77748459	A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis
Q35201910	A clinical role for peripheral blood lymphocyte infusions and perspectives on collection
Q77398534	A comparative study of a new, fully automated procedure and the standard mononuclear cell program using the Cobe Spectra for peripheral blood stem cell collection
Q45233063	A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production
Q91628315	A drastic change in protein intake may cause a rapid decline of residual renal function after initiation of peritoneal dialysis
Q45333254	A last resort modality using cryofiltration apheresis for the treatment of cold hemagglutinin disease in a Veterans Administration hospital
Q46317783	A model to predict optimal dialysate flow.
Q78064986	A new concept of bioartificial liver based on a fluidized bed bioreactor
Q77398669	A new device for selective removal of CD4+ T cells
Q50243970	A new device for selective removal of CD4+ T cells. 1998.
Q82670493	A new device to monitor blood volume in hemodialysis patients
Q53880559	A new endotoxin adsorber: first clinical application.
Q73641984	A new method for removal of albumin-binding uremic toxins: efficacy of an albumin-dialysate
Q44964360	A new treatment for endotoxemia with direct hemoperfusion by polymyxin immobilized fiber. 1984.
Q47300379	A novel method for dry weight assessment in hemodialysis patients: utilization of inferior vena cava flat ratio to correct for individual variations in vessel diameter.
Q48549126	A novel plasma filtration therapy for hepatic failure: preclinical studies
Q84585232	A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate
Q74442896	A patient with severe acute pancreatitis successfully treated with a new critical care procedure
Q46307222	A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis
Q44904224	A possible involvement of the carboxymethylation process in carpal tunnel syndrome in hemodialysis patients
Q50981049	A preliminary report on multiple family discussion groups for patients with chronic medical illness and its repercussions in the management of the hemodialysis process.
Q43421772	A randomized controlled study on the effects of acetate-free biofiltration on organic anions and acid-base balance in hemodialysis patients
Q44101215	A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis
Q40422803	A report of two cases of Kawasaki disease treated with plasma exchange
Q34619660	A review of leukofiltration therapy for decreasing the morbidity associated with cardiopulmonary bypass and acute inflammatory bowel disease
Q77392678	A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
Q50244008	A simplified centrifuge for the separation and processing of blood cells. 1967.
Q84871634	A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites
Q33606716	A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis
Q92075687	A suicide attempt with sevelamer in a hemodialysis patient
Q104482669	A threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34+ cell monitoring based on the experience from two Japanese university hospitals
Q80322551	AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases
Q61660698	Abdominal Aortic Calcification is an Independent Predictor of Cardiovascular Events in Peritoneal Dialysis Patients
Q77392719	Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Q79663881	About the role of prohepcidin as an indicator of iron status in dialysis patients
Q81647376	Abstracts from the 3rd Slovenian Congress of Nephrology
Q85640186	Acceleration of iron utilization after intravenous iron administration during activated erythropoiesis in hemodialysis patients: a randomized study
Q35199899	Access in therapeutic apheresis.
Q81537215	Achievement of the Japanese Society for Dialysis Therapy guideline targets for mineral metabolism measures: one Japanese university center result
Q46205144	Acinetobacter lwoffii peritonitis in a patient receiving continuous ambulatory peritoneal dialysis
Q98880010	Acute Acalculous Cholecystitis in Very Elderly Peritoneal Dialysis Patient
Q54249021	Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy.
Q48178119	Acute Splenic Sequestration Crisis After Red Blood Cell Exchange for Acute Chest Syndrome in an Adult With Sickle β-Thalassemia: What Went Wrong?
Q30939185	Acute and subacute effect of rheopheresis on microvascular endothelial function in patients suffering from age-related macular degeneration
Q73641937	Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis
Q46733527	Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss
Q86418976	Acute intradialytic cardiac function and inflammatory cytokine changes during high-efficiency online hemodiafiltration with acetate-free and standard dialysis solutions
Q43288971	Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury
Q35200770	Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes
Q47710597	Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients
Q86595453	Additional reduction in serum phosphorus levels by pulverized lanthanum carbonate chewable in hemodialysis patients
Q86052313	Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis
Q60484797	Adipokines in Peritoneal Dialysis: Relevant Clinical Impact According to Body Composition
Q87362344	Adiponectin levels in hemodialysis patients
Q77398646	Adsorbent: a determinant for the future development of therapeutic apheresis
Q35200780	Adsorption column for myasthenia gravis treatment: Medisorba MG-50.
Q90678208	Adsorption kinetics for high mobility group box 1 (HMGB1) protein in a polyacrylonitrile hemofiltration membrane
Q47619614	Adsorption of Nafamostat Mesilate on AN69ST Membranes: A Single-Center Retrospective and In Vitro Study.
Q64882947	Adsorption of Soluble Immunoglobulin-Type Adhesion Molecules to Cellulose Acetate Beads.
Q43975590	Adsorption of endotoxin by beta2-microglobulin adsorbent column (Lixelle): the new approach for endotoxinemia
Q54445426	Adsorptive depletion of CD14⁺CD16⁺ proinflammatory monocyte phenotype in patients with generalized pustular psoriasis: clinical efficacy and effects on cytokines.
Q37642895	Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications
Q77392815	Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera
Q90831502	Adverse Effect of Antithrombotic Medications on Bleeding Events and Comparison of Antithrombotic Agents in Hemodialysis Patients
Q37813815	Adverse events in therapeutic apheresis: a single center survey of various therapies
Q46088073	Affinity hemodialysis for antiviral therapy. I. Removal of HIV-1 from cell culture supernatants, plasma, and blood
Q54543009	Age-Related Differences of Organism-Specific Peritonitis Rates: A Single-Center Experience.
Q87249588	Aggravation of Cerebral Oxygenation due to Intradialytic Hypotension Induced by Blood Volume Reduction During Hemodialysis: A Case Report
Q93146638	Aging, Disease, and Therapeutic Apheresis
Q88695250	Albumin Apheresis for Artificial Liver Support: In Vitro Testing of a Novel Filter
Q47388655	Albumin Dialysis as a Bridge From Total Hepatectomy to Liver Transplantation for Fulminant Hepatitis With Toxic Syndrome
Q38471055	Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis
Q38471083	Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy
Q48256558	Albumin leakage in online hemodiafiltration, more convective transport, more losses?
Q36473219	Albumin regeneration in liver support-comparison of different methods
Q48357684	Aldosterone and Insulin Resistance: Vicious Combination in Patients on Maintenance Hemodialysis.
Q35201902	Allogeneic hematopoietic stem cell transplantation
Q73641975	Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia
Q85560877	Alpha-galactosidase A activity levels in Turkish male hemodialysis patients
Q42789854	Alpha-tocopherol administration decreases serum urate levels in hemodialysis patients
Q42774516	Amanita ibotengutake intoxication treated with plasma exchange
Q85046124	Amounts of bile acids and bilirubin removed during single-pass albumin dialysis in patients with liver failure
Q38484584	An Australian experience with the molecular adsorbents recirculating system (Mars).
Q57623222	An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)
Q40106842	An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).
Q50245032	An evaluation of polymethylmethacrylate plasma separator by animal experiment. 1983.
Q50245064	An experimental artificial liver utilizing extracorporeal metabolism with sliced or granulated canine liver. 1963.
Q104751403	An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia
Q44884390	An overview of regular dialysis treatment in Japan (as of 31 December 2001).
Q42645795	An overview of regular dialysis treatment in Japan (as of 31 December 2002).
Q57221657	An overview of regular dialysis treatment in Japan (as of 31 December 2004)
Q43232033	An overview of regular dialysis treatment in Japan (as of 31 December 2007).
Q41670601	An overview of regular dialysis treatment in Japan (as of 31 December 2012).
Q81626798	An overview of regular dialysis treatment in Japan as of 31 December 2003
Q96773126	An unique case of macular oedema following rituximab treatment for antibody mediated rejection in kidney transplant recipient
Q83251538	An unusual left-sided tunneled catheter in a hemodialysis patient
Q80113956	Analysis for the optimal blood draw speed to collect sufficient peripheral blood mononuclear cells by COBE Spectra
Q48210943	Analysis of Follow-Up Methods of Vascular Access and Patient Outcomes in Hemodialysis at a Tertiary Care Hospital in China.
Q33254027	Analysis of hemodynamics during blood purification therapy using a newly developed noninvasive continuous monitoring method
Q42210059	Analysis of protein removal properties during cryofiltration apheresis using the Evaflux-5A plasma fractionator in a patient with hepatitis C virus-associated cryoglobulinemic glomerulonephritis
Q51572489	Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Q54706396	Angiopoietin balance in septic shock patients treated by direct hemoperfusion with polymyxin b-immobilized fiber.
Q84871592	Angiopoietin balance in septic shock patients with acute lung injury: effect of direct hemoperfusion with polymyxin B-immobilized fiber
Q81226582	Angiotomographically-proven left innominate vein occlusion in dialysis patients with prior left internal jugular vein catheterization presenting with arm swelling after ipsilateral access creation: report of four cases
Q100418812	Angled, long-segment central venous occlusion in a hemodialysis patient recanalized by a novel "two-step" strategy based on percutaneous superior vena cava puncture
Q87085873	Ankle brachial index in hemodialysis patients
Q51288027	Ankle-Brachial Index and Long-Term (10 Years) Survival of Nondiabetic Hemodialysis Patients.
Q87229518	Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients
Q77516347	Antibody elimination by apheresis in living donor liver transplant recipients
Q37872050	Antibody reactivity of a standardized human serum protein solution against a spectrum of microbial pathogens and toxins: comparison with fresh frozen plasma
Q30426760	Antibody response after single H1N1 influenza vaccine in chronic dialysis patients
Q39067559	Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan
Q43288968	Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients
Q34646725	Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome
Q33328179	Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management.
Q34251652	Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome
Q34251660	Apheresis for renal disease.
Q73810051	Apheresis for rheumatic and other autoimmune conditions: where do we stand?
Q36739895	Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management
Q34557119	Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases
Q34316327	Apheresis in lupus nephritis
Q34218048	Apheresis in the treatment of cholesterol embolic disease
Q33328183	Apheresis in thoracic organ transplantation.
Q34557103	Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies.
Q43076042	Apheresis induces oxidative stress in blood cells
Q78493242	Apheresis of immune diseases and apheresis using immunological specificity
Q33979762	Apheresis registry in France: indications, techniques, and complications. French Registry Study Group
Q33606731	Apheresis techniques and cellular immunomodulation
Q50123610	Apheresis technologies and clinical applications: the 2000 International Apheresis Registry.
Q48534944	Apheresis technologies and clinical applications: the 2002 international apheresis registry
Q48385180	Apheresis technologies and clinical applications: the 2005 International Apheresis Registry
Q45243475	Apheresis technologies and clinical applications: the 2007 International Apheresis Registry
Q34449794	Apheresis technology for prevention and regression of atherosclerosis.
Q33606743	Apheresis technology for prevention and regression of atherosclerosis: an overview
Q78597034	Apheresis therapy for living-donor liver transplantation: experience for apheresis use for living-donor liver transplantation at Kyoto University
Q33916821	Apheresis treatment in Lambert-Eaton myasthenic syndrome
Q92511593	Application of a hemodialysis clearance prediction model using quantitative structure-pharmacokinetic relationship analysis
Q33607838	Applications of membrane technologies for therapeutic apheresis
Q51962969	Approach to acute renal failure with multiple myeloma: role of plasmapheresis.
Q92038458	Are Currently Used Bioimpedance Methods in Hemodialysis Comparable for Calculating Dialysis Dose?
Q73573926	Are nucleated red cells significant in patients with thrombotic thrombocytopenic purpura?
Q40293319	Arterial Access Port: A Shunt-Less Vascular Access Using a Blind-Ending Artificial Graft Anastomosed to the Brachial Artery.
Q83680417	Arteriovenous access closure in hemodialysis patients with refractory heart failure: a single center experience
Q84149183	Arteriovenous fistula intimal tear: think before you sneeze
Q43816221	Arteriovenous grafts in the thigh: an excellent hemodialysis vascular access when arm vasculature is exhausted
Q36473238	Artificial liver support system in China: a review over the last 30 years
Q42832612	Ascites from patients with encapsulating peritoneal sclerosis augments NIH/3T3 fibroblast proliferation
Q92486348	Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy
Q87229521	Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial
Q73810060	Ash Split Catheter for vascular access in apheresis
Q90484119	Assessing Extracellular Volume Excess in Dialysis Patients
Q87085978	Assessment of dialysis dose in critically ill maintenance dialysis patients
Q33284441	Assessment of lower limb ischemia with measurement of skin perfusion pressure in patients on hemodialysis
Q46665613	Assessment of plasma antioxidant status in hemodialysis patients.
Q85471730	Association Between Angiotensin-Converting Enzyme 2 and Coronary Artery Calcification in Patients on Maintenance Hemodialysis Therapy
Q90416925	Association Between Body Composition and Glomerular Hyperfiltration Among Chinese Adults
Q89494269	Association Between Dialysis Modalities and Risk of Coronary Artery Disease: A Population-Based Cohort Study in Taiwan
Q40215267	Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.
Q39897138	Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients
Q88510075	Association between Parathyroid Hormone and Cardiovascular Disease
Q42962580	Association between body mass and mortality in maintenance hemodialysis patients
Q42962579	Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
Q99567528	Association between pill burden and interdialytic weight gain in patients with hemodialysis: a multi-center cross-sectional study
Q50547384	Association between platelet-related hemostasis impairment and functional iron deficiency in hemodialysis patients.
Q92030281	Association of Hepcidin With Anemia Parameters in Incident Dialysis Patients: Differences Between Dialysis Modalities
Q51098383	Association of Lead aVR T-wave Amplitude With Cardiovascular Events or Mortality Among Prevalent Dialysis Patients.
Q91613771	Association of Low Serum Potassium Levels and Risk for All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Q92808073	Association of Lower Serum Bilirubin With Loss of Residual Kidney Function in Peritoneal Dialysis Patients
Q90295055	Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease
Q89163904	Association of Preoperative Mean Arterial Pressure With the Primary Failure of Brescia-Cimino Arteriovenous Fistula Within the First 7 Days Following Surgery in Hemodialysis Patients
Q91286394	Association of Vitamin D Receptor Gene Polymorphism With the Risk of Nephrolithiasis
Q96825677	Association of bioimpedance-derived 50-kHz phase angle as marker of body composition with electrical parameters regarding the Cole-Cole model
Q83180841	Association of heart valve calcification with malnutrition-inflammation complex syndrome, beta-microglobulin, and carotid intima media thickness in patients on hemodialysis
Q54314433	Association of increased indoleamine 2, 3-dioxygenase with impaired natural killer cell activity in hemodialysis patients.
Q42789859	Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
Q53084788	Association of pretransplant renal replacement therapy duration with outcome in kidney transplant recipients: a prevalent cohort study in Slovenia.
Q114083070	Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients
Q88223316	Associations of Peritoneal Glucose Load With Male Sexual Dysfunction and Depression in Peritoneal Dialysis Patients
Q81303925	Asymptomatic hyperleukocyturia in hemodialysis patients analyzed by the automated urinary flow cytometer
Q85265926	Asymptomatic left atrial thrombus in a dialysis-dependent patient free of thrombogenic abnormalities
Q39309248	At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature
Q81537211	Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic
Q38668292	Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting
Q48149654	Atypical Hemolytic Uremic Syndrome in Low Resource Settings: Which Options Do We Have?
Q48102410	Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens
Q57182291	Atypical hemolytic-uremic syndrome: An update on pathophysiology, diagnosis and treatment
Q87086144	Atypical vascular access for dialysis patients via persistent left superior vena cava
Q90604175	Audit of Hemodialysis in Children Weighing Less than 20 kg in an African Pediatric Nephrology Unit
Q48279507	Author's Reply to Oka and Colleagues.
Q48285222	Authors Should Pay Attention to the Confounding by Indication of Observational Study Using Propensity Score
Q81012217	Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy
Q81647420	Autoimmune-associated congenital heart block: treatment of the mother with immunoadsorption
Q96163185	Autologous arteriovenous fistula was failed for the spontaneous axillary artery dissection in a female hemodialysis patient
Q77398571	Autologous blood donation preceding coronary artery bypass graft operation in a hemodialysis patient
Q77392851	Automated plateletpheresis does not cause an increase in platelet activation in volunteer donors
Q44993708	Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures
Q34775364	B cells and immunoglobulins dependent mechanisms in rheumatoid arthritis: a possible rationale of the extracorporeal immunomodulation for rheumatoid arthritis.
Q34485649	Background and indications for protein A-based extracorporeal immunoadsorption.
Q44844739	Bacteriological qualities of dialysis fluid in Japan as of 31 December 2006.
Q81537205	Balance between bone morphogenetic proteins and their antagonists in kidney injury
Q33802496	Balancing (yin-yang) hypothesis for assessment of effective apheresis therapies.
Q48338646	Barriers to Effective Case Management for Disabled Patients on Hemodialysis.
Q48104695	Bartonellosis in Chronic Kidney Disease: An Unrecognized and Unsuspected Diagnosis.
Q47630860	Baseline and Time-Averaged Values Predicting Residual Renal Function Decline Rate in Japanese Peritoneal Dialysis Patients
Q77398550	Basic clinical study of an easy and effective leukocytapheresis by the use of nonwoven polyester filter
Q35199912	Basic steps for increasing the rate of autogenic vascular accesses for hemodialysis
Q100432736	Bed-sided short-duration Renal Replacement Therapy provide a possible option to treat Non-critical COVID-19 in maintenance hemodialysis (MHD) patients in public health crisis
Q51643058	Beneficial Effect of Endovascular Therapy and Low-Density Lipoprotein Apheresis Combined Treatment in Hemodialysis Patients With Critical Limb Ischemia due to Below-Knee Arterial Lesions.
Q59392756	Beneficial Therapeutic Effect of Plasmapheresis After Unsuccessful Treatment With Corticosteroids in Two Patients With Severe Toxic Epidermal Necrolysis
Q43859876	Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema.
Q42774517	Beraprost sodium, an orally active prostaglandin I(2) analog, improves renal anemia in hemodialysis patients with peripheral arterial disease
Q91821572	Bernd Hohenstein appointed as Editor representing the European Group - International Society for Apheresis
Q87010746	Best practice for diabetic patients on hemodialysis 2012
Q81960830	Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients
Q35200794	Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis
Q57794929	Better Oral Hygiene Habits Are Associated With a Lower Incidence of Peritoneal Dialysis-Related Peritonitis
Q33606712	Bilirubin adsorbent column for plasma perfusion
Q35200791	Bilirubin adsorption column Medisorba BL-300.
Q45233067	Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Q36473242	Bioartificial liver: its pros and cons
Q96308320	Biochemical Evaluation of Processed Ascites in Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy
Q50243962	Biocompatibility in membrane plasmapheresis: the necessity of global understanding. 1987.
Q36566683	Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis
Q90798054	Bioimpedance Spectroscopy-Based Fluid Status in Combined Dialysis Compared With Hemodialysis and Peritoneal Dialysis: A Cross-Sectional Study
Q47800187	Biological Agents and Therapeutic Plasma Exchange: Can They Coexist in the Future?
Q43232029	Biological effect of anaphylatoxin C5a on the generation of anti-inflammatory substances in leukocyte adsorption
Q74581831	Birth of the concept and the development of extracorporeal immunomodulation
Q44521011	Birth weight and end-stage diabetic nephropathy in later life: a Japanese multicenter study.
Q40451914	Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial.
Q38827154	Blood Pressure and Mortality in Hemodialysis Patients: A Systematic Review of an Ongoing Debate
Q33298428	Blood flow analysis of the head and lower limbs by the laser Doppler blood flowmeter during LDL apheresis
Q53656284	Blood monocyte count may be a predictor of vascular access failure in hemodialysis patients.
Q84438720	Blood pressure measurements and carotid intima media thickness in hemodialysis patients
Q77392776	Blood purification for critical care medicine: endotoxin adsorption
Q82925031	Blood purification for critical illness: cytokines adsorption therapy
Q78493234	Blood purification procedures and their related short- and long-term effect on patients
Q35200777	Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb
Q77398592	Blood purification therapy in cancer treatment
Q47755940	Body Composition and Inflammation in Hemodialysis Patients
Q88263400	Bone Histomorphometry in an Osteoporotic Hemodialysis Patient Treated With Denosumab
Q53245471	Bone histology in chronic kidney disease-related mineral and bone disorder.
Q84166953	Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis
Q53378633	Brief history of low-density lipoprotein apheresis.
Q46575110	Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy
Q48319383	Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin.
Q90325948	Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review
Q96692565	By Using Overdispersed Model, Lower Serum Albumin Level Is Associated with Increased Risk of Hospital Admission and Length of Stay in Hospital among Incident Hemodialysis Patients
Q84070043	C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis
Q91591877	C-Reactive Protein: From Biomarker to Trigger of Cell Death?
Q52978028	C1q: a multifunctional ligand for a new immunoadsorption treatment.
Q96163597	COVID-19 in dialysis patients in Japan: Current status and guidance on preventive measures
Q46919958	Calcium and phosphorus control in patients undergoing hemodialysis: from the view-points of activities of daily living
Q81337725	Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients
Q43859871	Calcium supplement increase on the second day of sequential two day leukapheresis
Q80653961	Calcium, phosphorus, cardiovascular events and all-cause mortality in hemodialysis patients: a single-center retrospective cohort study to reassess the validity of the Japanese Society for Dialysis Therapy guidelines
Q90955343	Calcium-Polystyrene Sulfonate Decreases Inter-Dialytic Hyperkalemia in Patients Undergoing Maintenance Hemodialysis: A Prospective, Randomized, Crossover Study
Q90768425	Can Helicobacter pylori Colonization Affect the Phosphate Binder Pill Burden in Dialysis Patients?
Q48098928	Can Lipoprotein Apheresis Offer a Therapeutic Role in the Management of Patients With Refractory Angina and Raised Lipoprotein(a)?
Q57183127	Can Living Transplant Donors Refuse Blood Transfusion? Case Reports of Living Kidney Transplantation From Jehovah's Witnesses
Q79346603	Can a decreasing ultrafiltration profile affect the dialytic dose administered?
Q77398616	Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
Q43274535	Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
Q77392733	Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?
Q51063761	Can serological tests tell us something about latent tuberculosis in hemodialysis patients?
Q84592761	Capillary electrophoretic profile of β2-microglobulin intermediate associated with hemodialysis
Q33417543	Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?
Q36168605	Cardiac troponin T in patients with kidney disease
Q43779764	Cardiothoracic ratio association with mortality in patients on maintenance peritoneal dialysis
Q39145892	Cardiovascular and Stroke Risk in Japanese Hemodialysis Patients With Atrial Fibrillation.
Q36168610	Cardiovascular calcification in patients with end-stage renal disease
Q83765255	Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis
Q81303680	Care resources for the aging population
Q91143056	Caregiving for Older Adults Requiring Hemodialysis: A Comparison Study
Q80653972	Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients
Q48121463	Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
Q58860419	Cascade Filtration in the Therapy of the Dry Form of Age-related Macular Degeneration
Q91793914	Case of Chronic Cough Caused by Accidental Inhalation of Lanthanum Carbonate Granules
Q85639862	Case of erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with thalidomide and plasma exchange
Q43705636	Case of peritoneal dialysis-related peritonitis and associated tunnel infection due to group G streptococcus
Q46889869	Case reports of successful therapeutic plasma exchange in severe amitriptyline poisoning
Q46044471	Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome
Q48450786	Case reports on emergency treatment of cardiovascular syndromes through heparin-mediated low-density lipoprotein/fibrinogen precipitation: a new approach to augment cerebral and myocardial salvage
Q44054000	Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis
Q44665981	Catheter-related atrial thrombus in a patient on hemodialysis.
Q48466112	Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan
Q51201330	Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
Q39877049	Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions
Q51206759	Cell-free artificial liver support.
Q36473244	Cell-free artificial liver support: design of appropriate clinical studies
Q51836071	Cellsorba.
Q79832170	Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration
Q77392675	Centrifugal leukocyte apheresis for ulcerative colitis
Q48695499	Cerebral blood flow in patients with peritoneal dialysis by an easy Z-score imaging system for brain perfusion single-photon emission tomography
Q46436528	Challenges in the therapy of secondary hyperparathyroidism
Q46229554	Change in coronary artery calcification score due to cinacalcet hydrochloride administration
Q85639225	Change of chylous ascites during low-density lipoprotein apheresis in a patient with idiopathic nephrotic syndrome
Q73726209	Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis
Q77790035	Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis
Q38906392	Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study
Q77392706	Changes in donor apheresis in Japan
Q87152646	Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study
Q50991504	Changes in indications for therapeutic plasma exchange over the last 27 years in Croatia.
Q46229564	Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy
Q35187621	Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis
Q92725437	Changes in pH and electrolytes during therapeutic plasma exchange in patients with liver diseases and factors predictive of these changes
Q77398694	Changes in phenytoin concentrations in blood and cerebrospinal fluid caused by direct hemoperfusion in a patient intoxicated with phenytoin
Q77398531	Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis
Q77392741	Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis
Q77398541	Changes in platelet demand in association with the spread of autologous peripheral blood progenitor cell transplantation
Q87562272	Changes in serum asymmetric dimethylarginine and endothelial markers levels with varying periods of hemodialysis
Q89005440	Changes in the Expression of Circulating microRNAs in Systemic Lupus Erythematosus Patient Blood Plasma After Passing Through a Plasma Adsorption Membrane
Q56957868	Changes in volumetric hemodynamic parameters induced by fluid removal on hemodialysis in critically ill patients
Q43547402	Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure.
Q73297347	Changes of plasma fibronectin in patients treated with cryofiltration for an extended period
Q47998571	Changing Trends in Therapeutic Plasmapheresis: An Indian Perspective.
Q77398587	Changing scenario of therapeutic apheresis in India in the last 14 years
Q99567504	Changing the Terminology from Kidney Replacement Therapy to Kidney Support Therapy
Q48112497	Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis
Q42789866	Characteristics of 20-year survivors undergoing maintenance hemodialysis
Q40522864	Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy
Q80697351	Characteristics of patients on hemodialysis therapy for more than 30 years
Q48279529	Characterization of Fractionation Membranes in an Animal Model of Double Filtration Lipoprotein Apheresis
Q50452246	Characterization of the cation-binding capacity of a potassium-adsorption filter used in red blood cell transfusion.
Q51288024	Chronic Hemodialysis in Small Children.
Q92455005	Chronic Kidney Disease-Associated Pruritus and Quality of Life in Malaysian Patients Undergoing Hemodialysis
Q91541154	Chronic Renal Failure as a Possible Risk Factor for Allergic Reaction in Therapeutic Plasma Exchange Using Fresh Frozen Plasma
Q87362306	Chronic antibiotic-refractory diversion pouchitis successfully treated with leukocyteapheresis
Q51207887	Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
Q46131113	Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease
Q73297353	Chronic severe thrombotic thrombocytopenic purpura (TTP)
Q43495110	Chylous ascites observed during catheter insertion
Q82632904	Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients
Q37599960	Cinacalcet in hyperfunctioning parathyroid diseases
Q40025205	Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
Q53360210	Circuit life versus bleeding risk: the impact of achieved activated partial thromboplastin time versus achieved filtration fraction.
Q79832181	Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism
Q87686539	Citrate Anticoagulation in Tandem Membrane Plasma-Exchange or Immunoadsorption and Hemodialysis in Patients With Immunological Diseases and Dialysis-Dependence
Q50796606	Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.
Q33366848	Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load
Q33395569	Citrate anticoagulation during post-dilution hemodiafiltration with a high cut-off (Theralite) membrane.
Q46556703	Citrate anticoagulation for single-needle hemodialysis: safety and efficacy
Q96586581	Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbind® Affinity blood filter - approved for the treatment of COVID-19 patients
Q92774506	Clinical Application of Apheresis in Very Small Dogs Weighing <8 kg to Pediatric Patients
Q91414317	Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection
Q38962225	Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock
Q44549739	Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis
Q77392786	Clinical application and effectiveness of low-density lipoprotein apheresis in the treatment of coronary artery disease
Q35201906	Clinical applications of CD34+ cell-selected peripheral blood stem cells
Q38203573	Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
Q112242493	Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome: A Swedish retrospective observational study
Q35201922	Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction
Q57217041	Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan
Q86052315	Clinical effects of pulse high-volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome
Q88177322	Clinical effects of the new phosphorus binder, bixalomer in hemodialysis patients switched from sevelamer hydrochloride
Q80380393	Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure
Q81012254	Clinical evaluation of pneumonia-associated rhabdomyolysis with acute renal failure
Q33606749	Clinical experience and future directions for low-density lipoprotein apheresis in the United States
Q57217023	Clinical experiences of bixalomer usage at our hospital
Q50685782	Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
Q45968684	Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
Q43274537	Clinical issues regarding cinacalcet hydrochloride in Japan
Q33328682	Clinical outcome in three patients with postpartum hemolytic uremic syndrome treated with frequent plasma exchange
Q43288970	Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane
Q43427754	Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder
Q83180853	Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients
Q92045741	Clinical presentation and management of acquired thrombotic thrombocytopenic purpura: a case series of 55 patients
Q46229567	Clinical study of cinacalcet in Japan
Q50245036	Clinical thermofiltration: initial application. 1985.
Q84070028	Clinical trials in apheresis
Q42986562	Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients
Q44957374	Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients
Q50244005	Closed continuous-flow centrifuge. 1968.
Q50981784	Cognitive-psychomotor functions and nutritional status in maintenance hemodialysis patients: are they related?
Q91628340	Cohort study with patients older than 80 years with stage 5 chronic kidney failure on hemodialysis vs conservative treatment: Survival outcomes and use of healthcare resources
Q85270017	Cold Hemodiafiltration for Exertional Heat Stroke Resulting in Multiple Organ Failure
Q88781011	Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease
Q34775327	Combination of therapeutic apheresis and therapeutic ventricular assistance for end-stage heart failure patients
Q46436529	Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
Q82925022	Combining continuous endotoxin apheresis and continuous hemodiafiltration in the treatment of patients with septic multiple organ dysfunction syndrome
Q81226590	Comment on "Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension" by Fujisaki et al
Q63255619	Communications
Q91040131	Comparative Evaluation of Five Different Methods of Anti-ABO Antibody Titration: An Aid for ABO-Incompatible Organ Transplants
Q44884396	Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins in their capability to reduce erythrocyte adhesiveness/aggregation in the peripheral blood
Q77392728	Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis
Q77398545	Comparative study of efficacy of plasma exchange versus intravenous gammaglobulin treatment on acute postinfectious polyradiculoneuropathy: a preliminary report
Q43076046	Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis
Q91538493	Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites
Q80653957	Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis
Q84148345	Comparison between whole and intact parathyroid hormone assays
Q87152716	Comparison of 2-week versus 4-week dosing intervals of epoetin beta pegol on erythropoiesis and iron metabolism in hemodialysis patients
Q91781186	Comparison of Blood Compatibility in Various Membrane Materials for Continuous Renal Replacement Therapy
Q57460536	Comparison of Paricalcitol and Calcitriol in Dialysis Patients With Secondary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Studies
Q47566254	Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators
Q90475271	Comparison of Solute Removal Properties Between High-Efficient Dialysis Modalities in Low Blood Flow Rate
Q85046111	Comparison of acetate-free citrate hemodialysis and bicarbonate hemodialysis regarding the effect of intra-dialysis hypotension and post-dialysis malaise
Q77392873	Comparison of acute physiology and chronic health evaluation III and II for prediction of mortality in multiple organ failure patients treated by plasma exchange
Q96016527	Comparison of bioelectrical impedance analysis in healthy pregnant women and patient on hemodialysis
Q43288964	Comparison of citrate anticoagulation during plasma exchange with different replacement solutions
Q43076062	Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia
Q43975597	Comparison of different treatment regimens in a case of homozygous familial hypercholesterolemia
Q84871622	Comparison of free light chain removal by four blood purification methods
Q73285443	Comparison of fresh frozen plasma with a standardized serum protein solution following therapeutic plasma exchange in patients with autoimmune disease: a prospective controlled clinical trial
Q40815178	Comparison of immunomodulation by cyclosporin A and azathioprine on pancreatic xenograft survival
Q77516354	Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis
Q50457562	Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.
Q98458268	Comparison of peritoneal function within the first one year of peritoneal dialysis between diabetic and non-diabetic patients
Q44774863	Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis
Q40106776	Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis
Q87686548	Comparison of the Pharmacological Effects of Paricalcitol Versus Calcitriol on Secondary Hyperparathyroidism in the Dialysis Population
Q83310909	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy
Q77392737	Comparison of the adsorption ability between tryptophan and modified tryptophan columns
Q96220243	Comparison of the albumin dialysis devices Molecular Adsorbent Recirculating System and ADVanced Organ Support in critically ill patients with liver failure - a retrospective analysis
Q91975868	Comparison of the circulatory effects of continuous renal replacement therapy using AN69ST and polysulfone membranes in septic shock patients: A retrospective observational study
Q85280653	Comparison of the effect of the same dose of a 4-weekly continuous erythropoietin receptor activator administered once every 2 or 4 weeks in hemodialysis patients
Q40493449	Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy
Q91635425	Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study
Q43040164	Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy
Q101405401	Complicated Peritoneal-Dialysis-Associated Peritonitis Caused by Brevibacterium
Q50682165	Complications of Permanent Hemodialysis Catheter Placement; Need for Better Pre-Implantation Algorithm?
Q40639586	Complications of leukocytapheresis
Q54278549	Complications of native arteriovenous fistula: the role of color Doppler ultrasonography.
Q81303920	Complications of therapeutic plasma exchange: experience with 4857 treatments
Q88223293	Compositional Analysis of Coronary Artery Calcification in Dialysis Patients in vivo by Dual-Energy Computed Tomography Angiography
Q46665609	Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis
Q40606021	Concentration of progenitor cells collected from bone marrow fluid using a continuous flow cell separator
Q48155587	Conceptual framework for holistic dialysis management based on key performance indicators
Q90045828	Congress Report: 12th World Congress of the International Society for Apheresis and the 40th Annual Meeting of Japanese Society for Apheresis
Q81870388	Congress president's report: 3rd Slovenian Congress of Nephrology
Q84149154	Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells
Q90226442	Consequence of Elevated Fibroblast Growth Factor 23 Levels in Acute Kidney Injury, Renal Recovery and Overall Survival in Intensive Care Unit Patients After Major Surgery
Q77295764	Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach
Q54485775	Construct of Dialysis Employee Satisfaction: Acquiring Satisfaction Factors and Their Contributions.
Q48184448	Continuous Renal Replacement Therapy in Successful Treatment of a Patient With Hyperlipidemic Acute Pancreatitis.
Q50732351	Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration.
Q43910870	Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure.
Q83765262	Continuous hemodiafiltration for potential amniotic fluid embolism: dramatic responses observed during a 10-year period report of three cases
Q45233059	Continuous hemodiafiltration in pediatric critical care patients
Q43638893	Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure
Q74442873	Continuous hemofiltration/hemodiafiltration in critical care
Q42789860	Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients.
Q38246655	Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations
Q87637891	Continuous renal replacement therapy in a patient with pulmonary embolism receiving extracorporeal membrane oxygenation
Q35199907	Continuous subcutaneous insulin infusion in patients with diabetes mellitus
Q85560893	Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia
Q46436541	Control of parathyroid function in patients with a short history of hemodialysis.
Q89544553	Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis
Q36168622	Convective dialysis therapies, current status and perspective
Q77392899	Conventional care of fulminant hepatic failure: medical and surgical aspects
Q79797725	Coronary artery calcification, coronary artery stenosis and hyperphosphatemia in hemodialysis patients
Q83310879	Coronary plaque morphology using virtual histology-intravascular ultrasound analysis in hemodialysis patients
Q44140077	Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patients.
Q90045832	Corporate Sponsors
Q92369021	Corporate Sponsors
Q97537938	Corporate Sponsors
Q101566171	Corporate Sponsors
Q33349509	Correcting immune imbalance: the use of Prosorba column treatment for immune disorders
Q48697930	Correction of Metabolic Alkalosis and Elevated Calcium Levels by Sodium Chloride in a Hemodialysis Patient With Inadequate Chloride Intake
Q91487613	Correction of hypercalcemia in a patient of acute kidney injury on continuous renal replacement therapy by the use of commercially available solutions
Q49146178	Correlation of coronary artery calcification with pre-hemodialysis bicarbonate levels in patients on hemodialysis
Q95417069	Corrigendum
Q95417077	Corrigendum
Q95550856	Corrigendum
Q95587711	Corrigendum
Q47960872	Cost-Effectiveness of Maintenance Hemodialysis in Japan
Q47578116	Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis
Q53408153	Could iron deficiency also affect platelet-related hemostasis impairment in hemodialysis patients?
Q43968865	Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism
Q88748999	Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders
Q74442858	Critical care apheresis
Q54385652	Critical care apheresis: hepatic failure.
Q74442885	Critical care by cytapheresis
Q77392711	Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitors
Q77398565	Cryofiltration apheresis for major ABO-incompatible kidney transplantation
Q77398629	Cryofiltration apheresis in the United States
Q77392923	Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases
Q83251529	Cryofiltration in the treatment of cryoglobulinemia and HLA antibody-incompatible transplantation
Q33328679	Cryosupernatant plasma exchange in the treatment of antiphospholipid antibody syndrome with lupus nephritis
Q83680445	Cuff-related problems with a tunneled cuffed venous catheter
Q45325657	Current Status of Hepatitis C Virus-Infected Maintenance Hemodialysis Patients in Japan.
Q38264394	Current clinical applications of extracorporeal photochemotherapy.
Q80118471	Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients
Q51836083	Current devices and new trends in theraputic apheresis.
Q33361710	Current status of therapeutic plasma exchange in Korea
Q33606706	Current therapeutic apheresis technologies for inflammatory bowel disease
Q34449822	Current topics on centrifugal plasmapheresis technologies
Q34449829	Current topics on cryofiltration technologies
Q34449836	Current topics on cytapheresis technologies.
Q40674239	Current topics on cytokine removal technologies
Q77295779	Current topics on immunoadsorption therapy
Q34449842	Current topics on low-density lipoprotein apheresis
Q77295748	Current topics on therapeutic apheresis technologies: had they already reached a limit?
Q43812794	Current ways of treating dyslipidemias to prevent atherosclerosis.
Q44235198	Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: report of five cases.
Q79346592	Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients
Q77392790	Cytapheresis--the next 25 years: stem cell therapy
Q77392889	Cytapheresis: the first 25 years
Q78596986	Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients
Q43846299	DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulation
Q46085086	DNA methylation: hemodialysis versus hemodiafiltration
Q53792673	Daily Home Hemodialysis Is an Available Option for Renal Replacement Therapy in Spain.
Q80653947	Darbepoetin alfa (KRN321) administered intravenously once monthly maintains hemoglobin levels in peritoneal dialysis patients
Q80322572	Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous rHuEPO in Japanese dialysis patients
Q94842733	Darbepoetin alpha is highly cost-effective compared with epoetin alpha in the treatment of renal anemia: a brief report from a hemodialysis clinic in Japan
Q48272874	Daytime sleepiness and quality of life in peritoneal dialysis patients
Q47818875	Decongestion Versus Cytokine Clearance in Acute Heart Failure: Not All that Glitters is Gold
Q83680399	Decrease in reduced-form albumin among chronic kidney disease patients: new insights in cardiovascular complications
Q48187797	Decreased Expression of Thrombomodulin in Endothelial Cells by Fibroblast Growth Factor-23/α-Klotho
Q84070047	Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis
Q51602415	Decreasing After-Hours Hemodialysis in Hospitals.
Q90957916	Delayed Removal Technique in the Management of Hemodynamically Stable Patients With Mediastinal Catheterization: Two Case Reports and Literature Review
Q92270974	Denture Use Warning for Peritoneal Dialysis-Related Peritonitis
Q33335399	Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. PRODROMI Study Group
Q34775345	Designing an integrated extracorporeal therapy service quality system
Q43788030	Destructive Spondyloarthropathy in Patients on Long-Term Peritoneal Dialysis or Hemodialysis
Q84220896	Detection of dialysis access induced limb ischemia by infrared thermography in children
Q44884400	Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible adverse effects of leukocytapheresis using nafamostat mesilate as anticoagulant
Q91613433	Development and Preliminary Validation of a Depression Assessment Tool for Maintenance Hemodialysis Patients
Q51835553	Development of a device for selective removal of CD4+ T cells.
Q83680410	Development of a novel questionnaire evaluating disability in activities of daily living in the upper extremities of patients undergoing maintenance hemodialysis
Q73285456	Development of a rapid blood transfusion system with the capability of blood purification
Q50243993	Development of a specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis. 1993.
Q43846304	Development of affinity microparticles for extracorporeal blood purification based on crystalline bacterial cell surface proteins
Q35201918	Development of reduced-intensity hematopoietic stem cell transplantation in the National Cancer Center Hospital, Japan
Q50243986	Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system. 1996.
Q44235202	Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus
Q84149149	Diabetic kidney disease: act now or pay later--World Kidney Day, 11 March 2010: we must act on diabetic kidney disease
Q36566664	Diagnosis and treatment of depression in dialysis patients
Q39127610	Diagnostic Accuracy of Serum Cystatin C for the Evaluation of Renal Dysfunction in Diabetic Patients: A Meta-Analysis
Q39312111	Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patients
Q41162370	Dialysis Withdrawal: Impact and Evaluation of a Multidisciplinary Deliberation Within an Ethics Committee as a Shared-Decision-Making Model
Q39026900	Dialysis method alters the expression of microRNA-33a and its target genes ABCA1, ABCG1 in THP-1 macrophages
Q84220855	Dialysis patients after kidney graft failure: Slovenian experience
Q33915604	Dialysis patients refusing kidney transplantation: data from the Slovenian Renal Replacement Therapy Registry
Q80118468	Dialysis update in Japan
Q77392805	Dialysis-related amyloidosis and clinical significance of extracorporeal removal of beta2-microglobulin
Q44225880	Dialyzability and pharmacokinetics of sitafloxacin following multiple oral dosing in infected hemodialysis patients
Q39388765	Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.
Q91750132	Diastolic Dysfunction, an Underestimated New Challenge in Dialysis
Q57215113	Did Lanthanum Carbonate Improve Prognosis in Patients Requiring Chronic Hemodialysis in the Kawashima Study?
Q52909815	Differences in Clinical and Pathological Features of Renal Cell Carcinoma Between Japanese Patients After Kidney Transplantation and Those on Hemodialysis.
Q86529202	Differences in reduction of coagulation factor XIII (F13) between immunoadsorption plasmapheresis and double filtration plasmapheresis
Q46436539	Different routes bridging calcium in Japanese hemodialysis patients
Q35201930	Differential indication of lipoprotein apheresis during pregnancy
Q46165023	Difficulty in improving malnutrition and low-grade inflammation in diabetic patients on peritoneal dialysis
Q35199916	Dilatation and declotting of arteriovenous accesses
Q43809878	Direct adsorption of lipoproteins from whole blood by DALI apheresis: technique and effects.
Q46850991	Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children
Q79832155	Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions
Q47980250	Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation
Q77392771	Directions for use: Plasmaflo AP-05H (L) Asahi plasma separator 0.5 m2
Q46895970	Distal radial artery pressures predict angiographic result and short-term patency outcome in hemodialysis patients with juxta-anastomotic inflow stenosis of radiocephalic fistula undergoing transradial angioplasty
Q91326193	Do Calcium-based Phosphate binders Accelerate or Prevent Coronary Artery Calcification in Dialysis Patients?
Q93365034	Do Pre-Hemodialysis Estimates of Extracellular Volume Excess Using Bioimpedance and N-Terminal Brain Natriuretic Peptide Correlate With Cardiac Chamber Size Measured by Magnetic Resonance Imaging?
Q39428285	Do automated red cell exchanges relieve priapism in patients with sickle cell anemia?
Q91056596	Does Apheresis Have Role on Course of Hypertriglyceridemia-Induced Acute Pancreatitis?
Q40482321	Does Guidewire Exchange Influence Infection Rate Related to Catheters Used for Vascular Access in Children on Chronic Hemodialysis?
Q50943813	Does Peritoneal Protein Transport Increase with Peritoneal Dialysis Therapy Duration and Lead to Extracellular Water Overload in Peritoneal Dialysis Patients?
Q38662775	Does Whey Protein Supplementation Improve the Nutritional Status in Hypoalbuminemic Peritoneal Dialysis Patients?
Q50463601	Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
Q43274536	Does cinacalcet improve the prognosis of dialysis patients?
Q43076040	Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
Q88171606	Donor With Membranous Nephropathy in Preemptive, Living-Related Kidney Transplantation
Q44048902	Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalation.
Q46665624	Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism
Q88177327	Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study
Q45233070	Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism.
Q40722482	Double Filtration Plasmapheresis in Treatment of Patients With Co-Infection of Hepatitis C and Human Immunodeficiency Virus
Q40765633	Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients
Q96586852	Double Filtration Plasmapheresis: Review of Current Clinical Applications
Q80322542	Double filtration plasmapheresis can decrease factor XIII Activity
Q42984933	Double filtration plasmapheresis could induce a favorable immune response for chronic hepatitis C therapy
Q40516588	Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein
Q77516377	Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report
Q84585225	Double filtration plasmapheresis in antibody-incompatible kidney transplantation
Q74442864	Double filtration plasmapheresis in critical care
Q45781215	Double filtration plasmapheresis in different diseases in Thailand
Q77392859	Double filtration plasmapheresis in the treatment of inflammatory polyneuropathy
Q77398623	Double filtration plasmapheresis maintains normal adhesion molecule levels
Q50245052	Double filtration plasmapheresis. 1980.
Q45295250	Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis
Q87860090	Double-filtration plasmapheresis for treatment of acute renal failure in a multiple myeloma patient
Q82632913	Down-modulation of toll-like receptor 2 expression on granulocytes and suppression of interleukin-8 production due to in vitro treatment with cellulose acetate beads
Q89174485	Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide
Q33361713	Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review
Q46191222	Drugs affecting the renin-angiotensin system and preservation of residual renal function in dialysis patients
Q46556713	Duplex-Doppler long-term follow-up of renal transplant artery stenosis: case controlled study
Q104503463	During COVID-19 stay at home even if you are a haemodialysis patient
Q48245718	Early Graft Loss in Two Recipients of Mate Kidneys From the Same Donor With Diabetic Nephropathy.
Q90416912	Early Mortality Rates After Commencement of Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
Q81960820	Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis
Q84585230	Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism
Q38471075	Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning
Q33349535	Early relapse of thrombotic thrombocytopenic purpura during therapeutic plasma exchange associated with Acinetobacter anitratus bacteremia
Q41928420	Earthquake Preparedness Among Japanese Hemodialysis Patients in Prefectures Heavily Damaged by the 2011 Great East Japan Earthquake
Q83251541	Ecchymosis and purpura associated with an arteriovenous fistula
Q53130971	Echinococcal cyst of the kidney presenting as an abdominal mass.
Q115527618	Ectopic Calcification as Abnormal Biomineralization
Q40503590	Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis
Q92871346	Effect of Blood Pump Flow and Arteriovenous Fistula Blood Flow on the Blood Pressure and Cardiac Function in Patients Undergoing Maintenance Hemodialysis
Q51572494	Effect of Cellulose Acetate Beads on Interleukin-23 Release.
Q53670139	Effect of Cellulose Acetate Beads on the Release of Transforming Growth Factor-β.
Q85639067	Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis
Q93024668	Effect of Hemodialysis on the Red Blood Cell Life Span in Patients with End-Stage Kidney Disease
Q92414627	Effect of Improving Volume Overload on Home Blood Pressure Variability in Hemodialysis Patients
Q89426625	Effect of Increased Blood Flow Rate on Hemodialysis Tolerability and Achieved Urea Reduction Ratio
Q91850907	Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial
Q93146347	Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy
Q90226725	Effect of Neutral pH Icodextrin Peritoneal Dialysis Fluid on Mesothelial Cells
Q39433889	Effect of On-Line Hemodiafiltration on P-Wave Dispersion in Children
Q48175035	Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study
Q52927710	Effect of Scavenging Circulating Reactive Carbonyls by Oral Pyridoxamine in Uremic Rats on Peritoneal Dialysis.
Q86987167	Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure
Q88414247	Effect of Temperature on Granulocyte and Monocyte Adsorption to Cellulose Acetate Beads
Q100959943	Effect of Type 2 Diabetes Mellitus on Efficacy and Safety of Therapeutic Apheresis for Severe Hypertriglyceridemia
Q92537716	Effect of Vitamin D Supplementation on Vascular Function and Inflammation in Patients with Chronic Kidney Disease: A Controversial Issue
Q44984480	Effect of alfacalcidol therapy on the survival of chronic hemodialysis patients
Q87086082	Effect of arteriovenous hemodialysis shunt location on cardiac events in patients having coronary artery bypass graft using an internal thoracic artery
Q57216624	Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients
Q38471048	Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure
Q78596996	Effect of filgrastim administration for steady-state mobilization of peripheral blood stem cells
Q83765243	Effect of heparin on conformation of the β2-microglobulin molecule
Q43035937	Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load
Q42594742	Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia
Q79920093	Effect of lowering dialysate calcium on bone and mineral parameters related to adynamic bone disease
Q46575096	Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients
Q73297340	Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome
Q40483193	Effect of plasma exchange on the circulating IL-6 levels in a patient with fatal hemophagocytic syndrome associated with bile ductopenia
Q80380396	Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients
Q45416873	Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients
Q85560871	Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients
Q85265270	Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients
Q46044465	Effect of sevelamer hydrochloride on bone in experimental uremic rats
Q81303696	Effect of skin care with an emollient containing a high water content on mild uremic pruritus
Q47817730	Effect of switching to nocturnal thrice-weekly hemodialysis on clinical and laboratory parameters: our experience
Q43428074	Effect of timing of the first cannulation on survival of arteriovenous hemodialysis grafts
Q84871596	Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S Filter
Q43877971	Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column
Q81647413	Effect over time of endotoxin adsorption therapy in sepsis
Q44467181	Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial
Q77516359	Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis
Q91040139	Effectiveness of Influenza Vaccine in Hemodialyzed Patients: A Retrospective Study
Q86839227	Effectiveness of Plasma Exchange for Acute Pancreatitis Induced by Hypertriglyceridemia During Pregnancy
Q43859874	Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure.
Q43076057	Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism
Q80322559	Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism
Q50123293	Effects of Bioreactor-Oxygenation During Extracorporeal Granulocytes Treatment in Septic Patients
Q40199793	Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis
Q28210475	Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function
Q87397134	Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients
Q48552962	Effects of Intradialytic Resistance Exercise on Protein Energy Wasting, Physical Performance and Physical Activity in Ambulatory Patients on Dialysis: A Single-Center Preliminary Study in a Japanese Dialysis Facility
Q86514964	Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis
Q92062595	Effects of Lower Past-Year Serum Sodium and Hyponatremia on Depression Symptoms and Cognitive Impairments in Patients With Hemodialysis
Q89163936	Effects of Lowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study
Q50789348	Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Q47260247	Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue
Q80025048	Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome
Q57623277	Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan
Q47993335	Effects of Sodium Concentration and Dialysate Temperature Changes on Blood Pressure in Hemodialysis Patients: A Randomized, Triple-Blind Crossover Clinical Trial.
Q92234632	Effects of Sustained-Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results
Q57467773	Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes
Q38461570	Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Q40241324	Effects of a Novel Peritoneal Dialysis: The Open Versus Laparoscopic Preperitoneal Tunneling Technique
Q53618158	Effects of a single, high oral dose of 25-hydroxycholecalciferol on the mineral metabolism markers in hemodialysis patients.
Q97588316	Effects of age and sex on the relationship between body fat area and kidney events in patients with chronic kidney disease
Q48123657	Effects of azilsartan compared to other angiotensin receptor blockers on left ventricular hypertrophy and the sympathetic nervous system in hemodialysis patients
Q57217030	Effects of change in the formulation of lanthanum carbonate on laboratory parameters
Q81226548	Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase--antineutrophil cytoplasmic autoantibody-associated vasculitis
Q43076076	Effects of dialysis purity on uremic dyslipidemia
Q85896746	Effects of different blood purification methods on serum cytokine levels and prognosis in patients with acute severe organophosphorus pesticide poisoning
Q43975594	Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.
Q42978225	Effects of eicosapentaenoic acid supplementation on immunoglobulin A nephropathy
Q52580796	Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients.
Q93045915	Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: A post-hoc analysis of a randomized controlled trial
Q100309566	Effects of exercise therapy on the persistence of physical function, exercise habits, and self-efficacy after cessation of exercise in patients undergoing hemodialysis: A nonrandomized control trial
Q54468306	Effects of extracorporeal treatment with Lixelle on the mortality and inflammatory responses to endotoxin-induced shock in rats.
Q34657453	Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates
Q41166494	Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum
Q51429484	Effects of handgrip training and intermittent compression of upper arm veins on forearm vessels in patients with end-stage renal failure.
Q46575092	Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis
Q48607244	Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
Q84592758	Effects of in-center nocturnal versus conventional hemodialysis on endothelial dysfunction
Q73297330	Effects of losartan on low-density lipoprotein apheresis
Q53577867	Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Q34449817	Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
Q80025037	Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study
Q77516340	Effects of operating conditions on selectivity of a plasma fractionator in double filtration plasmapheresis
Q53168677	Effects of peripheral blood mononuclear cells morphology on vascular calcification in uremic patients on maintenance hemodialysis.
Q84148352	Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis
Q83251514	Effects of renin-angiotensin-aldosterone system blockade on chlorhexidine gluconate-induced sclerosing encapsulated peritonitis in rats
Q44979380	Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange
Q45746332	Effects of switch from sevelamer hydrochloride to lanthanum carbonate on serum K and bone metabolic turnover
Q51068321	Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patients.
Q88177318	Effects of switching from sevelamer hydrochloride to bixalomer on laboratory parameters in hemodialysis patients
Q91538366	Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
Q52780295	Efficacy and Safety of Osimertinib in a Hemodialysis Patient With Advanced Non-Small Cell Lung Cancer.
Q51201324	Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
Q50243965	Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits. 1984.
Q33328652	Efficacy and limitation of apheresis therapy in critical care
Q33643207	Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns
Q44993703	Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan
Q91231079	Efficacy for Anemia and Changes in Serum Ferritin Levels by Long-Term Oral Iron Administration in Hemodialysis Patients
Q88414278	Efficacy of Cryofiltration for Treatment of Mixed Cryoglobulinemia: A Report of Four Cases
Q90657475	Efficacy of Long-Term Treatment With Tolvaptan to Prolong the Time Until Dialysis Initiation in Patients With Chronic Kidney Disease and Heart Failure
Q52990588	Efficacy of Low-Density Lipoprotein Apheresis in Salvaging Critical Limb Ischemia Induced by Acute Thrombotic Occlusion on Peripheral Artery Disease.
Q91594008	Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Q47975479	Efficacy of Substance Removal by Immunoadsorption With a Selective Plasma Separator
Q53817130	Efficacy of Tryptophan Immunoadsorption Plasmapheresis for Neuromyelitis Optica in Two Cases.
Q51085282	Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study.
Q46631805	Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients
Q57217883	Efficacy of continuous oral administration of lanthanum carbonate over 24 months
Q87534015	Efficacy of coronary artery screening tests and intervention in hemodialysis patients
Q83310915	Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model
Q73285460	Efficacy of different low-density lipoprotein apheresis methods
Q39500809	Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis
Q44904210	Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis
Q46766428	Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis
Q80322546	Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum
Q88154831	Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis
Q84070032	Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab
Q51754597	Efficacy of intra-arterial treatment for massive gastrointestinal bleeding in hemodialysis patients.
Q83180842	Efficacy of once-weekly intravenous administration of epoetin-beta as a maintenance treatment for anemia in Japanese hemodialysis patients: a multicenter, open-label clinical study
Q46436545	Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Q84166979	Efficacy of plasma exchange therapy for Kawasaki disease by cytokine profiling
Q50525116	Efficacy of separated system continuous venovenous hemofiltration in critical acute kidney injury.
Q45157283	Efficacy of series double continuous hemodiafiltration using two polymethyl methacrylate membrane hemofilters for patients with hypercytokinemia
Q50245055	Efficient membrane and adsorbent for artificial liver support system. 1978.
Q89484917	Eicosapentaenoic Acid and Prevalence of Cardiovascular Disease in Hemodialysis Patients
Q46051609	Electrocardiographic assessment of incident atrial fibrillation in hemodialysis patients
Q48461519	Elemental concentrations in scalp hair, nutritional status and health-related quality of life in hemodialysis patients
Q89426632	Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification
Q38254482	Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease
Q47414287	Elevated High Sensitivity C-Reactive Protein Increases the Risk of Microalbuminuria in Subjects With Cardiovascular Disease Risk Factors
Q89494226	Elevated Level of miR-551b-5p is Associated With Inflammation and Disease Progression in Patients With Severe Acute Pancreatitis
Q77398555	Elevated bradykinin and decreased carboxypeptidase R as a cause of hypotension during tryptophan column immunoabsorption therapy
Q46314043	Elimination of 2-arachidonoylglycerol action by direct hemoperfusion through immobilized polymyxin B fibers: an experimental study in conscious guinea pigs
Q45327935	Elimination of Plasma Cytokines Markedly Improves Non-Septic Multiple Organ Dysfunction Syndrome in Human Immunodeficiency Virus-Associated Hodgkin Lymphoma.
Q46766432	Elimination of liposomes by different separation principles used in low-density lipoprotein apheresis
Q57477407	Elusive therapeutic effect of PCSK9 inhibitors on lipoprotein(a) levels?
Q53681323	Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.
Q43274538	Emerging roles of cinacalcet hydrochloride in the management of CKD-MBD.
Q46556715	Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options
Q43288969	Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia
Q51698645	End-Stage Renal Disease in an Infant With Hajdu-Cheney Syndrome.
Q88887704	Endoscopic Superficialization of Arteriovenous Fistula: A Novel Technique With Common Devices
Q33802499	Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease
Q35199919	Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience
Q45368022	Endotoxin adsorption therapy for a patient with severe pneumonia resulting from novel influenza A (H1N1) virus infection
Q82925013	Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity
Q34619653	Endotoxin and cytokine removal in sepsis.
Q86495046	Enhanced vascular endothelial growth factor and inflammatory cytokine removal with online hemodiafiltration over high-flux hemodialysis in sepsis-related acute kidney injury patients
Q52987458	Eosinophilic Peritonitis Caused by Echinococcus granulosus in a Patient Receiving Maintenance Peritoneal Dialysis.
Q59354246	Epidemiological Survey of Patients With Hemodialysis Complicated by Hepatitis C in Japan
Q53854122	Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study.
Q54254044	Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient.
Q92125582	Esomeprazole vs pantoprazole effects on cyclosporine levels in kidney transplantation: A randomized clinical trial
Q47270068	Establishment of a blood purification system for renal failure rats using small-size dialyzer membranes
Q90657070	Estimating Plasma Volume in Hemodialysis Patients
Q47929159	Estimation of Glomerular Filtration Rate in Elderly Chronic Kidney Disease Patients: Comparison of Three Novel Sophisticated Equations and Simple Cystatin C Equation
Q33979739	Ethical lessons learned from the use of therapeutic plasma exchange in neurologic disease
Q53189486	Evaluating the Efficacy of Double-Filtration Plasmapheresis in Treating Five Patients With Drug-Resistant Pemphigus.
Q38900898	Evaluating the Imbalance Between Increasing Hemodialysis Patients and Medical Staff Shortage After the Great East Japan Earthquake: Report From a Hemodialysis Center Near the Fukushima Nuclear Power Plants
Q48177696	Evaluation of Dry Eye Using Anterior Segment Optical Coherence Tomography in Patients With End-Stage Renal Disease Undergoing Hemodialysis.
Q87489779	Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-β1 in Autosomal Dominant Polycystic Kidney Disease Patients
Q48308911	Evaluation of First-Line Sorafenib Treatment for Metastatic Renal Cell Carcinoma in Kidney Transplant Patients: A Single-Center Experience With Four Cases.
Q47353058	Evaluation of Intradialytic Hypertension Using Bioelectrical Impedance Combined With Echocardiography in Maintenance Hemodialysis Patients
Q38968402	Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis
Q100418809	Evaluation of Papp-A Levels in patients undergoing peritoneal dialysis and hemodialysis
Q39995286	Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan
Q50243979	Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. 1991.
Q91849173	Evaluation of a new measurement method of indoxyl sulfate in hemodialysis patients
Q50105668	Evaluation of a new method for measuring vascular access recirculation
Q74610187	Evaluation of adsorption selectivity dextran sulfate bound cellulose beads for the removal of anti-DNA antibodies
Q44328455	Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial
Q42774526	Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy
Q83310899	Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance
Q73297336	Evaluation of efficacy in platelet collection by the Haemonetics Component Collection System
Q45233056	Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis
Q80025042	Evaluation of markers to estimate volume status in hemodialysis patients: atrial natriuretic peptide, inferior vena cava diameter, blood volume changes and filtration coefficients of microvasculature
Q41680476	Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study
Q51169142	Evaluation of serological diagnosis tests for tuberculosis in hemodialysis patients.
Q40293333	Evaluation of the Infection Risk in Dialysis and Chronic Kidney Disease Patients Using an ATP Monitoring Assay
Q84871613	Evaluation of the effect of ulinastatin on the production of macrophage colony-stimulating factor in vitro for potential combination therapy with leukocyte adsorption
Q51466801	Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days.
Q54278544	Evaluation of urea reduction ratio estimated from the integrated value of urea concentrations in spent dialysate.
Q34316351	Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
Q83310885	Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease
Q80343346	Evidence-based medicine for apheresis: an ongoing challenge
Q93115072	Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
Q39010535	Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients
Q47642649	Excessive Attention to Major Complications in Frequent Dialysis: A Misleading Point for Patients' Quality of Life?
Q84166949	Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity
Q92316521	Exercise training during hemodialysis sessions: Physical and biochemical benefits
Q43288962	Expansion of blood volume increases the primary patency rate of arteriovenous fistulas for hemodialysis in patients with critical arterial quality
Q73641996	Experience with artificial liver support in 16 living related liver transplant recipients
Q45882721	Experimental study using heparin-immobilized adsorbent of EDA(+)fibronectin
Q81226567	Experimental therapies in renal replacement: the effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers
Q98879999	Exploring why female sex is a risk factor for arteriovenous fistula failure
Q40834776	Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections
Q47659712	Extracellular Water Excess and Increased Self-Reported Fatigue in Chronic Hemodialysis Patients.
Q35201937	Extracorporal low-density lipoprotein elimination by immunoadsorption
Q41103518	Extracorporeal Treatment in Severe Hypertriglyceridemia-Induced Pancreatitis
Q50135454	Extracorporeal adsorption of endotoxin
Q80113971	Extracorporeal albumin dialysis
Q33700415	Extracorporeal antibody elimination in neuroimmunological diseases
Q86895752	Extracorporeal depuration technique as treatment of acute kidney injury related to multiple myeloma
Q77398650	Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application
Q28202051	Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)
Q52908184	Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit.
Q44551206	Extracorporeal monocyte granulocytapheresis was effective for a patient of erythema nodosum concomitant with ulcerative colitis
Q94519532	Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
Q34775354	Extracorporeal photochemotherapy for the treatment of graft-versus-host disease
Q77392799	Extracorporeal photochemotherapy: a treatment for organ graft rejection
Q81960834	Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease
Q34316320	Extracorporeal plasma treatment in primary and recurrent focal segmental glomerular sclerosis: a review
Q33338252	Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Q34775351	Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application
Q33331019	Extracorporeal treatment of thrombotic microangiopathy: a ten year experience
Q48254962	FGF23 Level and Intima-Media Thickness Are Elevated From Early Stages of Chronic Kidney Disease
Q102130548	Factors Affecting the Doses of Roxadustat Versus Darbepoetin Alfa for Anemia Treatment in Hemodialysis Patients
Q100494009	Factors Associated with the Outcomes in Ulcerative Colitis Patients Undergoing Granulocyte and Monocyte Adsorptive Apheresis as Remission Induction Therapy: A Multicenter Cohort Study
Q85263763	Factors affecting circuit life during continuous renal replacement therapy in children with liver failure
Q104751332	Factors associated with hepcidin-25 levels in maintenance hemodialysis patients
Q43728038	Factors behind dialysis patient satisfaction: exploring their effects on overall satisfaction
Q46889866	Famciclovir and development of thrombotic thrombocytopenic purpura
Q51385635	Fasting serum leptin level correlates with mid-arm fat area in peritoneal dialysis patients.
Q47767813	Fate of Central Venous Catheters Used for Acute Extracorporeal Treatment in Critically Ill Pediatric Patients: A Single Center Experience
Q47980261	Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study
Q38199815	Feasibility of pediatric plasma apheresis in intensive care settings
Q73297333	Feasibility study on donor apheresis red cell and platelet simultaneous collection for blood center routine use
Q47230302	Features and instructions for use: Plasauto EZ Asahi plasmapheresis machine
Q47975463	Fibrinogen Reduction During Selective Plasma Exchange due to Membrane Fouling
Q77455022	Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience
Q43479958	Fibrinogen salvage during DF Thermo using Evaflux-5A plasma fractionators
Q36216951	Fibroblast growth factor 23 and its receptors
Q47817743	Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis
Q85263384	Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis
Q41649380	Filter leukapheresis for patients with ulcerative colitis: clinical results and the possible mechanism
Q53894956	Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate.
Q85046134	Finding of kidney arterial aneurysms in a case of Wegener's granulomatosis
Q45114690	First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study
Q34992576	First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.
Q53588949	Fluctuations in peripheral blood leukocyte and platelet counts and leukocyte recruitment with large volume leukocytapheresis in healthy volunteers.
Q78596975	Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers
Q51206710	Fluidized bed adsorbent systems for extracorporeal liver support.
Q83680439	Focal segmental glomerulosclerosis associated with invasive thymoma
Q84220876	Forty-eight-hour ambulatory blood pressure and carotid-femoral pulse wave velocity in hemodialysis patients
Q44591987	Fourth Slovenian Congress of Nephrology with International Participation
Q92844621	Frequency of Alterations in Apheresis-Related Abstracts Prior to Publications as Peer-Reviewed Articles
Q35200766	Fresenius AS.TEC204 blood cell separator
Q35201928	From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis
Q90438188	Fructus Psoraleae-Induced Severe Liver Injury and Treatment With Two Artificial Liver Support Systems: A Case Series Study
Q47817710	Fulminant peritonitis presumably caused by Panton-Valentine leukocidin-positive Staphylococcus aureus in a girl on peritoneal dialysis
Q33389407	Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer
Q44904206	Functional modulation of activated lymphocytes by time-varying magnetic fields
Q33328684	Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice.
Q48349647	Future Blood Vessel Puncture Procedure With Use of Head Mount Display
Q91798976	Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients
Q87418980	Gene expression analysis using a high-resolution DNA microarray of peripheral whole blood immediately before and after leukocytapheresis for rheumatoid arthritis
Q91535928	Generalized Pustular Psoriasis With CARD14 Variant c.526G>C (p.Asp176His) Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis
Q48340900	Generalized Pustular Psoriasis With IL-36 Receptor Antagonist Mutation Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis Accompanied by Reduced Serum IL-6 Level
Q84871607	Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis
Q93069604	Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics
Q83765228	Geriatric nutritional risk index may be a significant predictor of mortality in Korean hemodialysis patients: a single center study
Q89486434	Glomerular Filtration Rate and Initiation of Dialysis
Q86994913	Glucose-Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients
Q80025029	Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2
Q54572186	Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
Q95642298	Good response to cryofiltration in a patient with cryoglobulinemic vasculitis complicated with systemic lupus erythematosus
Q50243974	Granulocytapheresis as a possible cancer treatment. 1995.
Q41952126	Granulocyte and Monocyte Adsorption Apheresis for Generalized Pustular Psoriasis: Therapeutic Outcomes in Three Refractory Patients.
Q79832174	Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils
Q79832193	Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis
Q43467932	Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy
Q47980288	Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis
Q40525197	Granulocyte and monocyte adsorptive apheresis for patients with chronic hepatitis C virus infection: a report on six cases with high plasma viremia
Q52865797	Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect.
Q84149187	Granulocyte concentrate administered via apheresis for a pediatric patient with Kostmann's syndrome
Q46436555	Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.
Q48360596	Granulocyte-Monocyte Apheresis as an Adjuvant Therapy to Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis.
Q48272793	Granulocyte/Monocyte Adsorption Apheresis as a Novel Therapeutic Approach in the Treatment of an Impetigo Herpetiformis Case.
Q51459155	Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan.
Q84438728	Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption
Q92012682	Healthy Dietary Patterns But Not Fruit and Vegetables Keep Mortality Away: A Caution for Trials of Fruit and Vegetables in Dialysis Patients
Q120073835	Hearing assessment in Egyptian children with chronic renal failure on regular hemodialysis and renal transplantation children
Q93025016	Heart Valve Disease Predict Mortality in Hemodialysis Patients: A Single Center Experience
Q81303937	Heat stroke with multiple organ failure treated with cold hemodialysis and cold continuous hemodiafiltration: a case report
Q40503613	Hemoadsorption in Infection-Associated Rhabdomyolysis
Q74442868	Hemoadsorption in critical care
Q47674972	Hemodialysis Decreases the Concentration of Accumulated Plant Phenols in the Plasma of Patients on Maintenance Dialysis: Influence of Residual Renal Function.
Q64111939	Hemodialysis Product and Hip Fracture in Hemodialysis Patients: A Nationwide Cohort Study in Japan
Q44756499	Hemodialysis arteriovenous fistula-related complications and surgery in kidney graft recipients
Q90794985	Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults
Q44416528	Hemodialysis catheters
Q43288963	Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis
Q96954183	Hemodialysis efficiency management from the viewpoint of blood removal pressure
Q41685776	Hemodialysis immediately after cardiac catheterization is a risk factor for intradialytic hypotension
Q44568126	Hemodialysis patients born with a low birth weight should have a different time course of kidney diseases than those born with a normal birth weight
Q90679025	Hemodialysis patients with less extracellular water overload and smaller cardiac atrial chamber sizes are at greater risk of a fall in blood pressure during dialysis
Q38027896	Hemodialysis vascular access dysfunction: molecular mechanisms and treatment
Q52910489	Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5.
Q37605184	Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse?
Q46044464	Hemofiltration with the Cascade system in an experimental porcine model of septic shock
Q38191279	Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?
Q86495040	Hemoglobin maintenance and dosing strategies using intravenous continuous erythropoietin receptor activator in Japanese hemodialysis patients
Q84971600	Hemoperfusion with a polymyxin B fiber column decreases clotting activity
Q43232027	Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity
Q79346598	Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism
Q80994886	Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells
Q79346596	Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations
Q98566749	Hemophagocytic lymphohistiocytosis in patient on maintenance hemodialysis - case report
Q40667777	Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss
Q77455039	Heparin-Induced extracorporeal low-density lipoprotein precipitation futura, a new modification of HELP apheresis: technique and first clinical results
Q35201934	Heparin-induced extracorporeal low-density lipoprotein precipitation
Q59356903	Hepatitis B Virus Infection Among Patients With Chronic Kidney Disease Who Attended an Educational Program in Japan
Q45288093	Hepatitis B surface antigen is a better monitor of infectivity compared with antibody to hepatitis B core antigen in hemodialysis patients.
Q43040575	Hepatitis G virus exposure in dialysis staff
Q85560902	Hepatitis due to herbal medicine in a peritoneal dialysis patient
Q38078962	Hepcidin is a potential regulator of iron status in chronic kidney disease
Q58590679	Hepcidin/Ferritin Ratios Differ Among Non-dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis
Q88947188	High ANTI-PF4/Heparin Antibodies Titer and Thromboses Due to Infection 9 Months After Cessation of Heparin in Hemodialyzed Patient With Heparin-Induced Thrombocytopenia
Q40972429	High Hemoglobin Levels Maintained by an Erythropoiesis-Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment
Q97555377	High Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for Coronary Restenosis in Hemodialysis Patients undergoing Percutaneous Coronary Interventions
Q50958453	High Stroke Volume Variation Is an Independent Predictor for Decreased Blood Pressure During Hemodialysis.
Q57623230	High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease Patients
Q84592765	High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients
Q84220892	High cut-off membrane hemodiafiltration in myoglobinuric acute renal failure: a case series
Q57282146	High efficiency removal of cytokines and HMGB-1 by continuous hemofiltration with a dual layered polyethersulfone membrane: An ex vivo study
Q43171885	High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan
Q85560889	High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage
Q43846296	High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report.
Q91188532	Higher Cholesterol Level Predicts Cardiovascular Event and Inversely Associates With Mortality in Hemodialysis Patients: 10-Year Outcomes of the Q-Cohort Study
Q45732113	Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan
Q47801288	Historical perspective on plasmapheresis
Q77790028	History of the Japanese Society for Apheresis
Q38203572	Home blood pressure control after the great East Japan earthquake in patients on chronic hemodialysis
Q90986899	How Can I Manage Thrombocytopenia in Hemodialysis Patient? A Review
Q34251678	How Prosorba apheresis came to be used for rheumatoid arthritis: a personal historical perspective
Q36473227	How can liver toxins be removed? Filtration and adsorption with the Prometheus system
Q42978219	How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study
Q81647374	How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients
Q48112929	Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner.
Q54314415	Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure.
Q77790045	Hydrazine-conjugated cellulose for adsorption of glycated proteins
Q35187630	Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis
Q39330209	Hypertension Induced by Tyrosine-Kinase Inhibitors for the Treatment of Renal Cell Carcinoma in Hemodialysis Patients: A Single-Center Experience and Review of the Literature.
Q38254461	Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective
Q51759743	Hypoalbuminemia is also a marker of fluid excess determined by bioelectrical impedance parameters in dialysis patients.
Q77398641	Hypocalcemia secondary to citrate toxicity
Q47980331	Hypoglycemia in diabetic patients undergoing chronic hemodialysis
Q48117821	Hypoglycemic Emergency in Patients With Diabetic Kidney Disease
Q91286286	Hypothalamic Energy Regulatory Peptides in Chronic Kidney Disease
Q48039018	Hypovolemic Shock After Starting Hemodialysis due to Malposition of Femoral Double-Lumen Catheter
Q44122116	Ideal timing and predialysis nephrology care duration for dialysis initiation: from analysis of Japanese dialysis initiation survey
Q84070036	Identification of hemodialysis patients' common problems using the International Classification of Functioning, Disability and Health
Q77392689	Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins
Q92320500	Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease
Q88748118	Immunoadsorption With a Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis
Q50987733	Immunoadsorption as a Long-Term Therapy in Recurrent Focal Segmental Glomerulosclerosis After Renal Transplantation.
Q64899985	Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease.
Q45862151	Immunoadsorption for pregnancy-associated severe acquired hemophilia
Q77392763	Immunoadsorption for the treatment of bullous pemphigoid
Q40610908	Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial. Prosorba Trial Investigators
Q33979746	Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis
Q38027895	Immunoadsorption in dermatology
Q74052177	Immunoadsorption in dilated cardiomyopathy
Q40529213	Immunoadsorption in lupus myocarditis
Q39411539	Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor.
Q77392794	Immunoadsorption in systemic connective tissue diseases and primary vasculitis
Q35199887	Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy
Q39837503	Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia
Q74278311	Immunoadsorption of immunoglobulins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases
Q77398689	Immunoadsorption plasmapheresis in acute ataxic neuropathy
Q36473248	Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis
Q73883857	Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis
Q45869272	Immunological Analysis and Generation of Dendritic Cells From Lavage Fluid Obtained by Cell-Free and Concentrated Ascites Reinfusion Therapy
Q34992564	Immunomodulation by the autonomic nervous system: therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases.
Q35689907	Immunomodulation effects and clinical evidence of apheresis in renal diseases
Q77398612	Immunomodulation in transplant patients by cryofiltration
Q53222255	Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease.
Q84592780	Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis
Q96308336	Immunotherapy employing dendritic cell vaccination for patients with advanced or relapsed esophageal cancer
Q35201914	Immunotherapy exploiting the versatility of dendritic cells
Q77398596	Immusorba TR and Immusorba PH: basics of design and features of functions
Q50243989	Immusorba TR and Immusorba PH: basics of design and features of functions. 1998.
Q35200783	Immusorba TR and PH.
Q58085513	Impact of Dialysate Sodium Concentration Lowering on Home Blood Pressure Variability in Hemodialysis Patients
Q38901641	Impact of Lanthanum Carbonate on Prognosis of Chronic Hemodialysis Patients: A Retrospective Cohort Study (Kawashima Study).
Q48270066	Impact of Statins on Arteriovenous Fistulas Outcomes: A Meta-Analysis.
Q87249892	Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients
Q90607221	Impact of Vitamin D Receptor Gene Polymorphism on Chronic Renal Failure Susceptibility
Q92832237	Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study
Q46229549	Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism
Q46229545	Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study.
Q52882262	Impact of different types of resuscitation fluids on coagulation and continuous venovenous hemofiltration hemocompatibility in a porcine model.
Q42978214	Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients
Q89796756	Impact of infliximab administration before plasma exchange therapy on patients with Kawasaki disease
Q57217879	Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease
Q54390670	Impact of lipid apheresis on Egr-1, c-Jun, c-Fos, and Hsp70 gene expression in white blood cells.
Q85264607	Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis
Q42978195	Impact of plasma exchange on pharmacokinetic disposition of micafungin
Q43076069	Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis
Q42978206	Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients
Q46657632	Impact of sevelamer hydrochloride and the K/DOQI guidelines
Q41977866	Impact of the Fukushima Daiichi Nuclear Power Plant accident on hemodialysis facilities: an evaluation of radioactive contaminants in water used for hemodialysis
Q87653638	Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study)
Q47324559	Implications of Albumin Leakage for Survival in Maintenance Hemodialysis Patients: A 7-year Observational Study
Q39017481	Importance of Body Water in the Efficacy of Convective Solute Transport in Online Hemodiafiltration
Q91179385	Importance of Mean Platelet Volume in Predicting Cardiac Mechanics Parameters and Carotid-Intima Media Thickness in Children With End-Stage Renal Disease and Comparison With Healthy Children
Q45349458	Importance of isolated anti-hbc in detection of occult hepatitis B virus infection in hemodialysis patients
Q45348567	Importance of isolated anti-hbc in detection of occult hepatitis B virus infection in hemodialysis patients: reply
Q53505861	Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
Q73641952	Improved outcome prediction for patients with multiple organ failure undergoing continuous hemodiafiltration
Q45353441	Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative study
Q91593572	Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration
Q91530123	Improvement of clinical outcomes in dialysis: No convincing superiority in dialysis efficacy using hemodiafiltration vs high-flux hemodialysis
Q77455036	Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients
Q38496650	Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system.
Q78597027	Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease
Q36649825	Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis
Q92832419	In Memory of Professor Akira Yamamoto
Q101211389	In Vitro Comparison of the Endotoxin Adsorption by Blood Purification Devices
Q91760658	In Vitro Evaluation of Resistance and Warming Performance of a Small Blood Warmer on a Continuous Renal Replacement Therapy Circuit
Q36566679	In preparation for a treatment guideline for suitable vascular access repair in Japan
Q78064981	In vitro cell culture systems as the basis for an extracorporeal blood purification strategy in multiorgan failure treatment
Q44210536	In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion
Q84871618	In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration
Q44235193	In vitro evaluation of newly developed adsorbent for selective removal of glycosylated low-density lipoprotein.
Q85638933	In vivo kinetics of the uremic toxin p-cresyl sulfate in mice with variable renal function
Q82670482	Incidence and clinical outcomes of acute kidney injury requiring renal replacement therapy in Japan
Q97870217	Incidence of Shunt Infection among Patients on Maintenance Dialysis with Buttonhole Technique: Okinawa Hemodialysis Survey
Q46436562	Incidence of peripheral arteriosclerotic complications of the lower extremities in diabetic patients with chronic renal failure
Q57217036	Increase in the dosage amount of vitamin D3 preparations by switching from calcium carbonate to lanthanum carbonate
Q38471039	Increase of octanoate concentrations during extracorporeal albumin dialysis treatments
Q47353079	Increased Serum Level of IGF-1 Correlates With Better Cognitive Status in End-Stage Renal Disease Patients Undergoing Hemodialysis.
Q54314424	Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.
Q46556705	Increased ethyl mercury load in protein a immunoadsorption
Q86052306	Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients
Q80380404	Increased serum osteoprotegerin level in older and diabetic hemodialysis patients
Q44203315	Increasing gender difference in the incidence of chronic dialysis therapy in Japan
Q80118474	Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients
Q35201925	Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis
Q35199878	Indications of plasma exchanges for systemic vasculitides
Q53129762	Indirect ion selective electrode methods potentially overestimate peritoneal dialysate sodium losses.
Q91503627	Individualized Cool Dialysate as an Effective Therapy for Intradialytic Hypotension and Hemodialysis Patients' Perception
Q40503620	Infection Rates Following Buttonhole Cannulation in Hemodialysis Patients.
Q77392934	Inflammatory cytokine production enhancement in the presence of lipopolysaccharide after hepatic resection in cirrhotic patients
Q88637512	Influence of Blood Purification and Differential Injection Sites of Cold Saline on Transpulmonary Thermodilution Values
Q91503617	Influence of Physical Exercise on the Dialytic Adequacy Parameters of Patients on Hemodialysis
Q50887096	Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
Q39604194	Influence of Staff Encouragement on Perceived Burden of Dietary Restriction Among Patients Living Alone.
Q48860243	Influence of antiplatelet medications on bleeding events in hemodialysis patients
Q74052185	Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis
Q44008016	Influence of dialysis duration on the outcome of living kidney transplantation
Q81012246	Influence of intravenous drug abuse on native arteriovenous fistula thrombosis in chronic hemodialysis patients
Q79797695	Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics
Q47817719	Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
Q39236582	Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin
Q80322564	Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients
Q44057512	Influence of single low-density lipoprotein apheresis on the adhesion molecules soluble vascular cellular adhesion molecule-1, soluble intercellular adhesion molecule-1, and P-selectin.
Q77748449	Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers
Q50507273	Influence of the assay for measuring serum albumin on corrected total calcium in chronic hemodialysis patients.
Q39953267	Influenza Vaccination and Other Factors Related to the Development of Influenza-Like Illness Among Patients on Chronic Hemodialysis in a Japanese Dialysis Facility.
Q48301707	Inhibition of Inflammatory Cytokines and Induction of Myeloid-Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis
Q46631798	Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.
Q48508003	Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects
Q44904217	Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients
Q87686565	Integrative Examination of Motor Abilities in Dialysis Patients and Selection of Tests for a Standardized Physical Function Assessment
Q92436171	Intensity of renal replacement therapy and outcomes in critically ill patients with acute kidney injury: Critical appraisal of the dosing recommendations
Q39106204	Inter-Method Variability of Ferritin and Transferrin Saturation Measurement Methods in Patients on Hemodialysis
Q92925998	Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label Study
Q45056874	Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study
Q43232032	Intermittent plasmapheresis prevents recurrence in neuromyelitis optica
Q84438723	Intima media thickness and endothelial function in chronic hemodialysis patients
Q83251534	Intima-media thickness is associated with non-traditional risk factors and ischemic heart disease in hemodialysis patients
Q43873424	Intra-arterial treatment for massive subcutaneous hemorrhage in hemodialysis patients
Q98631651	Intradialytic Isometric Handgrip Exercise Does Not Cause Hemodynamic Instability: A Randomized, Cross-Over, Pilot Study
Q90226785	Intraocular Pressure Changes During Hemodialysis or Hemodiafiltration in End-Stage Renal Disease Patients
Q86052289	Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients
Q46665616	Intravenous alfacalcidol once weekly suppresses parathyroid hormone in hemodialysis patients
Q90183823	Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center
Q46657619	Introduction to sevelamer hydrochloride and its clinical effects
Q87534751	Investigation of factors affecting the six-minute walk test results in hemodialysis patients
Q79346590	Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis
Q45779952	Involvement of extracellular signal-regulated kinase in leukocyte adsorption-induced production of hepatocyte growth factor
Q53245474	Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
Q47214784	Involvement of p38MAPK in Impaired Neutrophil Bactericidal Activity of Hemodialysis Patients
Q34986849	Ionized alkaline water: new strategy for management of metabolic acidosis in experimental animals
Q51136033	Ipsilateral Basilic Vein Transposition in a Patient With a Pacemaker.
Q93100203	Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor-23
Q28210493	Iron status and the use of non-steroidal anti-inflammatory drugs in hemodialysis patients
Q46436534	Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines
Q50225607	Is Efficacy of the Anti-Cd20 Antibody Rituximab Preventing Hemolysis Due to Passenger Lymphocyte Syndrome?
Q38611698	Is High-Volume Online Hemodiafiltration Associated With Malnutrition?
Q57466376	Is Plasma exchange efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence
Q38851933	Is Regional Citrate Anticoagulation the Future of Hemodialysis?
Q88129691	Is granular formulation of lanthanum carbonate more effective than chewable tablets?
Q38471061	Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
Q46436558	Is lipoprotein (a)-apheresis useful?
Q50750546	Is parenteral phosphate replacement in the intensive care unit safe?
Q53482043	Is the timing of thallium injection in relation to hemodialysis treatments important?
Q50735158	Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism?
Q50140577	Italian Multicenter Study on Low-Density Lipoprotein Apheresis: retrospective analysis (2007).
Q39229652	Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey
Q92038495	JR-131, a Biosimilar of Darbepoetin Alfa, for the Treatment of Hemodialysis Patients With Renal Anemia: A Randomized, Double-Blinded, Parallel-Group Phase 3 Study
Q87418973	Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis
Q50502242	Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.
Q42982443	Japanese Society for Dialysis Therapy: clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C.
Q82670462	Japanese Society for Dialysis Therapy: presidential address upon reappointment
Q81537209	Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism
Q87010749	Japanese society for dialysis therapy clinical guideline for "Maintenance hemodialysis: hemodialysis prescriptions"
Q87010751	Japanese society for dialysis therapy clinical guideline for "hemodialysis initiation for maintenance hemodialysis"
Q86418499	Juvenile slow progressive antineutrophil cytoplasmic antibody-associated vasculitis diagnosed after kidney transplantation: a case report
Q53770765	Kidney Transplantation in Slovenia From 1970 to 2015.
Q44993720	Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil
Q98297763	L-carnitine supplementation versus cycle ergometer exercise for physical activity and muscle status in hemodialysis patients: A randomized clinical trial
Q96308275	LDL Apheresis-mediated Endothelial Activation Therapy to Severe-Peripheral Artery Disease (LETS-PAD) Study: Rationale and Study Design
Q77392913	LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia
Q77392684	LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy
Q46436549	LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy
Q79832158	LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis
Q43076035	Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis
Q91424649	Labile plasma iron levels in chronic hemodialysis patients treated by intravenous iron supplementation
Q96308281	Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM
Q43653562	Lactobacillus casei Peritonitis in Peritoneal Dialysis: A Rare Case and Literature Review
Q46766425	Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis
Q57220069	Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients
Q73641923	Large volume apheresis of autologous plasma and preparation of autologous fibrin glue from the plasma
Q57623236	Late Dialysis Start Did Not Affect Long-Term Outcome in Japanese Dialysis Patients: Long-Term Prognosis From Japanese Society of Dialysis Therapy Registry
Q93256616	Late increases in dialysis initiation after a massive disaster
Q85897125	Late-onset neurological symptoms in a child with diarrhea-associated hemolytic uremic syndrome
Q38444264	Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment
Q45245420	Left ventricular end-diastolic diameter is an independent predictor of mortality in hemodialysis patients
Q45345712	Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients
Q88335461	Legionella Pneumophila: A Renal Vasculitis Trigger?
Q57109076	Lessons from Japan's March 2011 earthquake regarding dialysis patients
Q37741281	Lessons from single cell organisms: insights into the antimicrobial and toxic effects of peritoneal dialysate bases
Q94435965	Letter to the editor
Q78493261	Leukapheresis in patients with previously untreated acute myeloid leukemia
Q35199880	Leukocytapheresis for rheumatic disease
Q40483199	Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications
Q77398664	Leukocytapheresis therapy by extracorporeal circulation using a leukocyte removal filter
Q53933055	Leukocytapheresis therapy for severe ulcerative colitis.
Q45067418	Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis
Q34775331	Leukocytapheresis using a leukocyte removal filter.
Q41649397	Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis
Q42681974	Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial
Q77392666	Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression
Q34521550	Leukocytoreduction for acute leukemia
Q43412188	Level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with non-infected catheters and arteriovenous fistula in a large Saudi hemodialysis center
Q48245521	Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial
Q90075748	Lidocaine-Propitocain Cream, a Eutectic Mixture of Local Anesthetics, Effectively Relieves Pain Associated With Vascular Access Intervention Therapy in Patients Undergoing Hemodialysis: A Placebo-Controlled, Double-Blind, Crossover Study
Q44552973	Lipid apheresis: the only therapeutic option for a very small group of cardiovascular patients with high low-density lipoprotein cholesterol or lipopoprotein(a) blood concentrations
Q77398634	Lipoprotein (a) immunapheresis in the treatment of familial lipoprotein (a) hyperlipoproteinemia in a patient with coronary heart disease
Q92167243	Lipoprotein-associated phospholipase A2 predicts lower limb ischemia in hemodialysis subjects
Q51294221	Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.
Q38439220	Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation
Q84595076	Liver support 2009: time for another revolution?
Q35015614	Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy
Q53390191	Localization and extent of peritoneal calcification in three uremic patients on continuous ambulatory peritoneal dialysis.
Q44884403	Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report
Q38464010	Long-Term Outcomes of Total Parathyroidectomy With or Without Autoimplantation for Hyperparathyroidism in Chronic Kidney Disease: A Meta-Analysis
Q47975335	Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis.
Q91871931	Long-Term Safety and Efficacy of JR-131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study
Q91040159	Long-Term Therapeutic Plasma Exchange Therapy as Effective Approach to Refractory Primary Acquired Pregnancy-Related Thrombocytopenic Purpura
Q46851259	Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients
Q33188162	Long-term catheters for apheresis and dialysis with surface treatment with infection resistance and low thrombogenicity
Q73810056	Long-term catheters for dialysis and apheresis: a double-edged weapon
Q33395566	Long-term citrate anticoagulation in chronic hemodialysis patients.
Q81960826	Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis
Q35187612	Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia
Q35187608	Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia
Q48576532	Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis
Q46631812	Long-term erythropoietin therapy improves response in myelodysplastic syndrome
Q74278335	Long-term improvement of idiopathic hypertrophic cranial pachymeningitis by lymphocytapheresis
Q51551542	Long-term natural history of acquired cystic disease of the kidney.
Q74442890	Long-term survivors with artificial liver support in fulminant hepatic failure
Q45015610	Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients
Q45012809	Longer dialysis times are associated with a lower chance of dementia among chronic hemodialysis patients
Q90267872	Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis
Q47948207	Loss of Residual Renal Function is Associated With Vascular Calcification in Hemodialysis Patients
Q43616214	Loss of amino acids into dialysate during hemodialysis using hydrophilic and nonhydrophilic polyester-polymer alloy and polyacrylonitrile membrane dialyzers.
Q90483923	Low Copeptin Levels in Patients With Intradialytic Hypotension
Q57825113	Low Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products
Q81337738	Low blood osteoprotegerin levels are a predictor to poor prognosis in Japanese patients on hemodialysis due to diabetic nephropathy
Q83765258	Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome
Q78064908	Low density lipoprotein apheresis by membrane differential filtration (cascade filtration)
Q42618108	Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia
Q74052165	Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies
Q78064917	Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center
Q87362189	Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients
Q47318835	Low molecular weight iron dextran increases fibroblast growth factor-23 concentration, together with parathyroid hormone decrease in hemodialyzed patients.
Q40522859	Low-Density Lipoprotein Apheresis Ameliorates Renal Prognosis of Cholesterol Crystal Embolism
Q90957834	Low-Volume Tidal Peritoneal Dialysis Is a Preferable Mode in Patients Initiating Urgent-Start Automated Peritoneal Dialysis: A Randomized, Open-Label, Prospective Control Study
Q54345197	Low-density lipoprotein adsorption therapy can restore drug sensitivity for immunosuppressants via inhibitory effects upon MDR-1 gene expression.
Q34449810	Low-density lipoprotein apheresis and changes in plasma components.
Q43076059	Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia
Q43076052	Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients
Q77392759	Low-density lipoprotein apheresis for focal glomerular sclerosis
Q77392782	Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results
Q45032463	Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
Q35187616	Low-density lipoprotein apheresis in the prevention of recurrent coronary heart disease: a review
Q35187618	Low-density lipoprotein apheresis in the treatment of peripheral arterial disease
Q82925044	Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial
Q42774510	Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia
Q77398661	Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits
Q35187604	Low-density lipoprotein apheresis: an overview
Q80653994	Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis
Q33777161	Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method
Q96308326	Lower Blood Return Temperature than Core Temperature as a Causal Factor of Decreased Cardiac Output Assessed by Transpulmonary Thermodilution during Blood Purification
Q92270957	Lower Serum Albumin Level Is Associated With an Increased Risk for Loss of Residual Kidney Function in Patients Receiving Peritoneal Dialysis
Q104753042	Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients
Q44993718	Lowering of oxidative stress in hemodialysis patients by dialysate cleaning: in relation to arteriosclerosis
Q39676582	Malnutrition in Renal Failure: Pleiotropic Diagnostic Approaches, Inefficient Therapy and Bad Prognosis.
Q46044479	Malnutrition-inflammation complex syndrome and hepatitis C in maintenance hemodialysis patients
Q81226543	Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation
Q46657618	Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy
Q38095645	Management of inherited atherogenic dyslipidemias in children
Q80994907	Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter
Q37599955	Management of mineral and bone disorder in chronic kidney disease: quo vadis?
Q40396100	Management of secondary hyperparathyroidism
Q96341900	Mass spectrometry of urinary β2 microglobulin oligomer in patients with proteinuria
Q46436564	Mathematical analysis of urea rebound in long-term hemodialysis patients
Q48134559	Matrix-Metalloproteinase-2 Predicts Arteriovenous Fistula Failure in Hemodialysis Patients.
Q46631810	Maxacalcitol is a possible less phosphatemic vitamin D analog
Q34992571	Meaning of low-density lipoprotein-apheresis for hypercholesterolemic patients at high risk for recurrence of coronary heart disease
Q44993715	Measurement of translymphatic fluid absorption using technetium-99m human serum albumin diethylenetriamine pentaacetic acid in continuous ambulatory peritoneal dialysis patients
Q53772189	Measuring platelet aggregation in dialysis patients with a whole blood aggregometer by the screen filtration pressure method.
Q77392904	Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases
Q94466321	Medium Cut-off Dialyzers in a Large Population of Hemodialysis Patients in Colombia: COREXH Registry
Q77392881	Membrane apheresis technology: historical perspective and new trends toward bioincompatible systems
Q33385909	Membrane plasma exchange for the treatment of thrombotic thrombocytopenic purpura
Q50245034	Membrane plasma separation. 1983.
Q34449848	Membrane plasmapheresis in the United States: a review over the last 20 years
Q77295771	Membrane processes for plasma separation and plasma fractionation: guiding principles for clinical use
Q34775335	Membranes for therapeutic apheresis.
Q92687724	Mental Effects of Excess Parathyroid Hormone in Hemodialysis Patients: A Possible Role for Parathyroid 2 Hormone Receptor?
Q88576749	Message from the New President of the Japanese Society for Dialysis Therapy
Q85775073	Message from the new president of the Japanese Society for Dialysis Therapy
Q85274584	Message from the president of the Japanese Society for Apheresis
Q54278542	Method for approximating colloid osmotic pressure in long-term hemodialysis patients.
Q84592776	Methoxy polyethylene glycol-epoetin beta (CERA) induced restless legs syndrome
Q73814746	Micro- and macrocirculatory effects of apheresis in patients with familial hyperlipidemia
Q51578236	Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis.
Q50245060	Microemboli-free blood detoxification utilizing plasma filtration. 1976.
Q33199427	Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases
Q48269022	Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension
Q44950135	Millennium Memorabilia Issue on Apheresis: part 2. Centrifugal devices, adsorbents, leukocyte filters, and extracorporeal immunomodulations
Q78597012	Miller Fisher syndrome and plasmapheresis
Q74610183	Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis
Q83680407	Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design
Q82632920	Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors
Q78596981	Mobilization factors of peripheral blood stem cells in healthy donors
Q44453009	Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis
Q64983894	Modification of the Dialysate Port of Plasma Separators for Safe Blood Purification in Japan.
Q48468313	Modified laparoscopic splenectomy: a beneficial technique for ABO-incompatible living donor renal transplantation candidates on hemodialysis
Q78493251	Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield
Q51243626	Monocarboxylate Transporter-1 Mediates the Protective Effects of Neutral-pH Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluid on Cell Viability and Apoptosis.
Q45066184	More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy
Q84166968	Morning hypertension determined by self-measurement at home predicts left ventricular hypertrophy in patients undergoing continuous ambulatory peritoneal dialysis
Q82925111	Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guidelines
Q45864249	Mourning the Loss of Dr. Akio Kawamura
Q38095643	Multi-modal imaging technologies in cardiovascular risk assessment
Q46118271	Multicenter study of long-term (two-year) efficacy of lanthanum carbonate
Q41750716	Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study
Q82981198	Multicenter study of plasma diafiltration in patients with acute liver failure
Q50468078	Multicenter study on the long-term (3-year) efficacy of lanthanum carbonate in dialysis patients.
Q40496286	Multicomponent donor apheresis in the Americas
Q91179427	Multiple Factors Including Infections and Antibiotics Affecting New-Onset Epilepsy in Hemodialysis Patients
Q40010621	Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study
Q84166939	My experiences with apheresis
Q34557111	Myasthenia gravis and Lambert-Eaton syndrome.
Q73297342	Myasthenic crisis with delayed recovery after plasmapheresis
Q40475300	Mycosis fungoides in a hemodialysis patient with intractable pruritus.
Q88090241	Mycotic Aneurysm of the Abdominal Aorta Complicated With Iliopsoas Abscess and Infectious Spondylodiscitis in a Long-Term Hemodialyzed Patient: A Rare but Serious Complication of Staphylococcus Aureus Bacteremia
Q53247835	Mycotic abdominal aortic aneurysm in a dialysis patient with catheter-related methicillin-resistant Staphylococcus aureus bacteremia.
Q52990592	Myocardial SPECT Images in Incident Hemodialysis Patients Without Ischemic Heart Disease.
Q33341390	Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience.
Q34274677	Myoglobin-induced apoptosis: two pathways related to endoplasmic reticulum stress
Q91135463	NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study)
Q96308284	Nafamostat mesilate inhibits linezolid metabolism via its antioxidant effects
Q47980236	Nanobiotechnology for the prevention of dialysis-related amyloidosis
Q33374298	National survey of hemapheresis practice in Hungary 2001-2004.
Q44993064	Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
Q90451629	Need for a Central Renal Registry in Pakistan
Q77748436	Neonatal alloimmune thrombocytopenia
Q92030310	Neurological Complications After Renal Transplantation: A Systematic Review and Meta-Analysis
Q89184981	Neurological and Psychological Changes in Hemodialysis Patients Before and After the Treatment
Q74052174	Neutrophil activation in immunoadsorption
Q40908831	New Method for the Approximation of Corrected Calcium Concentrations in Chronic Kidney Disease Patients
Q89041094	New Roles of Parathyroid Hormone
Q77398654	New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion
Q84438706	New approaches in the treatment of acute kidney injury
Q50245058	New artificial liver support system (plasma perfusion detoxification) for hepatic coma. 1978.
Q87562277	New bone formation induced by minimodeling in a hemodialysis patient treated with cinacalcet
Q50244003	New flow-through centrifuge without rotating seals applied to plasmapheresis. 1975.
Q46927358	New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant
Q50455258	New method of dialysate drainage flow analysis: an implication for automated peritoneal dialysis prescription.
Q50244010	New principle of closed system centrifugation. 1956.
Q79832148	New reimbursement for dialysis in Japan
Q41710373	New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease
Q80118479	New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver
Q77455017	New trends in apheresis
Q92260616	New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis-A Review
Q33361706	Nine years of cascade filtration for thrombotic thrombocytopenic purpura
Q61910968	No Evidence to Support the Use of Plasmapheresis for Age-Related Macular Degeneration
Q33417539	No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial
Q51503094	Non-invasive monitoring of hemodynamic changes during hemodialysis by the use of a newly developed admittance cardiograph.
Q40991285	Novel Blood Purification System for Regulating Excessive Immune Reactions in Severe Sepsis and Septic Shock: An Ex Vivo Pilot Study
Q44227454	Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism
Q46103273	Novel inflammatory marker in dialysis patients: YKL-40.
Q36988379	Novel regulators of phosphate homeostasis and bone metabolism
Q84148333	Nuclear chromatin-concentrated osteoblasts in renal bone diseases
Q48703205	Nutritional status evaluated by multi-frequency bioimpedance is not associated with quality of life or depressive symptoms in hemodialysis patients.
Q91535665	Observation of Granulocyte Adsorption in Adacolumn Cellulose Acetate Beads after Granulocytapheresis
Q80053481	Observation survey and invasive trial of chronic dialysis patients
Q92636182	Occlusion of a Peritoneal Dialysis Catheter by Fibrous Connective Tissue Covering the Intraperitoneal Catheter: A Case Report
Q45326980	Occult Hepatitis B Virus Infection With Increased Virus DNA Levels in a Chronic Hemodialysis Patient
Q83310923	Occult disseminated malignancy presenting as microangiopathic hemolytic anemia
Q82670533	Occult hepatitis B and hemodialysis patients need increased precautions with the interpretation of results
Q45350919	Occult hepatitis B virus infection in Japanese chronic hemodialysis patients
Q41680435	Occult hepatitis B virus infection in hemodialysis patients in Japan
Q42978199	Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study
Q38027897	Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration.
Q94646314	Ocular Manifestations in Hemodialysis Patients and Short-Term Changes in Ophthalmologic Findings
Q84220917	Ocular tuberculosis in a patient undergoing hemodialysis therapy
Q34500064	Off-line leukapheresis using leukofiltration for active ulcerative colitis: a case report.
Q88969208	On the Advantage of Glucose Delivery by On-Line Hemodiafiltration
Q45375569	On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center
Q74442878	On-line hemodiafiltration in critical care
Q50245044	On-line separation of macromolecules by membrane filtration with cryogelation. 1980.
Q43076073	One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis
Q92809598	One-Year Impact of Kidney Transplantation on Cardiac Abnormalities and Blood Pressure in Hemodialysis Patients
Q48135919	Online Hemodiafiltration Reduces Bisphenol A Levels
Q51714651	Optimum Conditions for the Efficacy and Safety of Cryofiltration Apheresis: An Analysis of Circuit Temperatures Depending on Plasma Flow Rate and Cooling Coil Lengths/Turns.
Q92518372	Oral Candida Colonization as a Risk Factor for Chronic Inflammation and Atherosclerosis in Hemodialysis Patients
Q92350208	Oral roxadustat three times weekly in ESA-naïve and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies
Q80343351	Osteal complications as first manifestation in a patient with primary Sjögren's Syndrome and with associated distal tubular acidosis (type 1) and chronic renal insufficiency
Q51797207	Osteopontin expression in vascular smooth muscle cells in patients with end-stage renal disease.
Q91821565	Our Thanks to ALL Healthcare Workers on the Frontlines Caring for Our Most Vulnerable
Q53854123	Our experience with epoetins in treating renal anemia.
Q43964614	Outcome and survival in different peritoneal dialysis modalities
Q33328674	Outcome of collagen vascular diseases by treatment with plasmapheresis
Q52967793	Outcome of patients on long term low-density lipoprotein apheresis with membrane differential filtration: a case study in three patients 14 years on treatment.
Q51747682	Outcomes of Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation in Small Children After Cardiac Surgery: Experience and Protocol From a Single Center.
Q40192509	Outcomes of non-tunneled non-cuffed hemodialysis catheters in patients on chronic hemodialysis in a resource limited sub-Saharan Africa setting.
Q37942689	Outcomes of salvage procedures for occluded autogenous radiocephalic arteriovenous fistula
Q45228290	Overview of regular dialysis treatment in Japan (as of 31 December 2005).
Q42789867	Overview of regular dialysis treatment in Japan (as of 31 December 2008).
Q43610757	Overview of regular dialysis treatment in Japan (as of 31 December 2009).
Q44632924	Overview of regular dialysis treatment in Japan (as of 31 December 2011).
Q46165025	Overview of regular dialysis treatment in Japan as of 31 December 2006.
Q74610153	Overview of therapeutic apheresis in the U.S.A.
Q78493256	Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis
Q51661397	Oxygen uptake efficiency slope as monitoring tool for physical training in chronic hemodialysis patients.
Q89041101	Parathyroid Hormone and Bone in Dialysis Patients
Q48239717	Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question
Q36234302	Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors
Q38078963	Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases
Q43076038	Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism.
Q84148350	Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan
Q42789861	Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study
Q46657613	Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients
Q46229560	Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics
Q51459147	Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism.
Q42251707	Paricalcitol reduces proteinuria in non-dialysis chronic kidney disease patients.
Q80653988	Partial blood recirculation: a new trial for prolonging filter life during continuous hemodiafiltration
Q84220872	Partial remission of resistant nephrotic syndrome after oral galactose therapy
Q83310872	Pathological role of aminolevulinate in uremic patients
Q34251643	Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins
Q92270817	Patient Selection for Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure
Q51136236	Patient-Specific Relationship Between Hydraulic Permeability of Microvasculature and the Extent of Burden of Excess Fluid in Hemodialysis Patients.
Q43608680	Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients
Q33371828	Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state
Q101566174	Paul S. Malchesky, D. Eng.: An acknowledgement of his contributions to the journal
Q38551615	Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis
Q88223350	Pelvic Artery Calcification Score Is a Marker of Vascular Calcification in Male Hemodialysis Patients
Q85640097	Pelvic abscess induced by a dormant peritoneal dialysis catheter without obvious intestinal perforation
Q120073832	Penile calciphylaxis in patients with end‐stage kidney disease undergoing dialysis: Invasive treatment and pain management
Q91275152	PentraSorb C-Reactive Protein: Characterization of the Selective C-Reactive Protein Adsorber Resin
Q35200787	Peptide based adsorbers for therapeutic immunoadsorption
Q77748453	Performance evaluation of plasma fractionation membrane
Q84592764	Perilipin-1 in hemodialyzed patients: association with history of coronary heart disease and lipid profile
Q57904696	Periodic Therapeutic Plasma Exchange in Patients With Moderate to Severe Chronic Myasthenia Gravis Non-Responsive to Immunosuppressive Agents: An Eight Year Follow-Up
Q46775875	Periodontal treatment reduces chronic systemic inflammation in peritoneal dialysis patients
Q84166964	Perioperative outcomes of laparoscopic radical nephrectomy for renal cell carcinoma in patients with dialysis-dependent end-stage renal disease
Q34557069	Peripheral blood progenitor cell transplantation
Q33364622	Peripheral digit ischemic syndrome can be a manifestation of postoperative thrombotic thrombocytopenic purpura.
Q54654659	Perirectal Abscess: Camouflaged as Culture Negative Peritonitis in a Continuous Ambulatory Peritoneal Dialysis Patient.
Q40106849	Peritoneal Dialysis Registry With 2012 Survey Report.
Q40391412	Peritoneal Dialysis Registry With 2013 Survey Report
Q48200226	Peritoneal Dialysis Related Peritonitis by Sphingomonas Paucimobilis
Q34459201	Peritoneal Dialysis is Limited by Kidney and Liver Volume in Autosomal Dominant Polycystic Kidney Disease
Q44560507	Peritoneal Dialysis-Related Peritonitis With Acinetobacter Ursingii
Q47190973	Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status.
Q84595085	Peritoneal clearance and transport of procalcitonin
Q104284354	Peritoneal dialysis in the days of COVID-19
Q83765266	Peritoneal dialysis with Takayasu arteritis: a report of three cases
Q101148716	Peritoneal dialysis-related peritonitis caused by Paracoccus yeei
Q83310930	Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium
Q97596511	Peritoneal dialysis-related peritonitis due to Corynebacterium striatum: an emerging multidrug-resistant pathogen
Q104751288	Peritoneal sodium removal compared to glucose absorption in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) with and without a day-time exchange
Q56771250	Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic etiology
Q59745139	Persistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients
Q80653976	Pharmacokinetic study of interleukin-2 following intravenous injection in hemodialysis patients with renal cell carcinoma
Q38444324	Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature
Q44716331	Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane
Q91593457	Phase I/II Pilot Study of Wilms' Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined With Conventional Chemotherapy in Patients With Head and Neck Cancer
Q83680392	Phenylacetic acid stimulates reactive oxygen species generation and tumor necrosis factor-α secretion in vascular endothelial cells
Q57176675	Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals
Q87686552	Phosphate Removal During Long Nocturnal Hemodialysis/Hemodiafiltration: A Study With Total Dialysate Collection
Q48121487	Phosphate or Phosphorus Removal During Nocturnal Hemodialysis: Are We Using Correct Terms?
Q74581818	Photopheresis and leukocytapheresis: cytapheresis treatment against immune-mediated diseases
Q84149197	Physical activity is necessary to prevent deterioration of the walking ability of patients undergoing maintenance hemodialysis
Q77295768	Physical principles in therapeutic apheresis
Q100695160	Physiological heating augments the anti-inflammatory reactions during Granulocyte/Monocyte apheresis: A in vitro study
Q43690757	Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis.
Q92817086	Pilot Study to Detect Changes in Blood Flow in the External Auditory Meatus During Hemodialysis
Q49072333	Planning a social activity to improve psychological well-being and quality of life of hemodialysis patients: a pilot study
Q40991272	Plasma Adiponectin Levels in Acute Liver Failure Patients Treated with Plasma Filtration with Dialysis and Plasma Exchange
Q89398519	Plasma Cystine Levels and Cardiovascular and All-Cause Mortality in Hemodialysis Patients
Q91204425	Plasma D-Dimer Level and the Failure of Forearm Autologous Arteriovenous Fistula in Patients With End-Stage Renal Disease
Q91613748	Plasma Exchange Downregulates Activated Monocytes and Restores Regulatory T Cells in Kawasaki Disease
Q91593553	Plasma Exchange Is Highly Effective for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single-Center Case Series
Q100516596	Plasma Exchange Therapy and COVID-19
Q92982573	Plasma Exchange Therapy to Reduce Mortality in Japanese Patients With Diffuse Alveolar Hemorrhage and Microscopic Polyangiitis
Q89585544	Plasma Exchanges for Refractory Evans Syndrome
Q91850972	Plasma Filtration Versus Centrifugation in Pediatric Therapeutic Plasma Exchange: Should the Diagnosis Define the Method?†
Q80653953	Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease
Q43769000	Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients
Q43462907	Plasma adsorption in critical care
Q45968675	Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.
Q77392697	Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column
Q50753112	Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies.
Q84871630	Plasma diafiltration therapy in patients with postoperative liver failure
Q42789857	Plasma exchange and tacrolimus therapy for focal segmental glomerulosclerosis collapsing variant and the cytokine dynamics: a case report
Q45864247	Plasma exchange for acquired hemophilia: a case report
Q52924037	Plasma exchange for acute attacks of demyelinating disease: detecting a Lazarus effect.
Q78597016	Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases
Q39294175	Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy
Q33328650	Plasma exchange for thrombocytopenia in antiphospholipid syndrome: a case report
Q34024394	Plasma exchange for treatment of myasthenia gravis: pathophysiologic basis and clinical experience.
Q30573928	Plasma exchange in Rasmussen's encephalitis
Q44775624	Plasma exchange in elderly patients
Q74442902	Plasma exchange in patients with toxic epidermal necrolysis
Q73641990	Plasma exchange in stiff-man syndrome
Q44797751	Plasma exchange treatment improves prognosis of antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis: a case-control study in 26 patients from a single center
Q85639416	Plasma exchange treatment in a case of colchicine intoxication
Q78025192	Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome
Q77392811	Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome
Q47349747	Plasma exchange-based plasma recycling dialysis system as an artificial liver support
Q80697356	Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose
Q36566660	Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines
Q84166944	Plasma separation by centrifugation and subsequent plasma filtration: impact on survival in a pig model of sepsis
Q35200774	Plasma separator Plasmaflo OP.
Q97535158	Plasma volume treated with double filtration plasmapheresis and outcomes of acute antibody-mediated rejection in kidney transplant recipients: A retrospective cohort study
Q77516382	Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes
Q34363025	Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts
Q44103494	Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience
Q33541679	Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis
Q77392838	Plasmapheresis combined with somatostatin is a successful treatment of porphyrias
Q77392824	Plasmapheresis followed by intravenous immunoglobulin in presensitized patients awaiting thoracic organ transplantation
Q77392868	Plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis of kidney allograft in adult recipients
Q77398575	Plasmapheresis for removal of myeloperoxidase antineutrophil cytoplasmic antibodies: a case report
Q77392854	Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid
Q35689912	Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases
Q34316339	Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Q33643218	Plasmapheresis in collagen vascular diseases
Q84538261	Plasmapheresis in diffuse alveolar hemorrhage as perinuclear antineutrophil cytoplasmic antibody-associated vasculitis relapse on hemodialysis
Q30818670	Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience
Q35199891	Plasmapheresis in immunologically mediated polyneuropathies
Q74248785	Plasmapheresis in renal disease
Q34251670	Plasmapheresis in the University of Malaya Medical Centre, Malaysia
Q34117648	Plasmapheresis in the dysproteinemias
Q33916827	Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations.
Q77392749	Plasmapheresis in the treatment of rapidly progressive glomerulonephritis
Q30711364	Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies.
Q77392829	Plasmapheresis in treatment of adrenoleukodystrophy
Q36016791	Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement
Q85046132	Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient
Q44487457	Plasmapheresis-refractory transplantation-associated thrombotic microangiopathy successfully treated with pravastatin and limaprost alfadex
Q46665619	Platelet (dys)function and plasma plasminogen levels in hemodialysis patients
Q50685795	Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.
Q42774523	Platelet function, activation and apoptosis during and after apheresis.
Q53613927	Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay.
Q47741565	Polymicrobial Bacteremia Involving Comamonas testosteroni in a Patient on Dialysis With Acute Appendicitis
Q44993711	Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure
Q50245029	Polyvinylalcohol membranes for plasma separation. 1983.
Q43288958	Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes
Q92680332	Portomesenteric venous gas: An unusual complication of peritoneal dialysis
Q92748420	Positive Association of Serum Adipocyte Fatty Acid Binding Protein Level With Peripheral Artery Disease in Hemodialysis Patients
Q84149198	Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis
Q48576546	Positive outcomes of high hemoglobin target in patients with chronic kidney disease not on dialysis: a randomized controlled study
Q44095990	Possibility of decrease in CYP1A2 function in patients with end-stage renal disease
Q87051496	Possible Sirolimus-Induced Acute Pancreatitis in a Renal Transplant Recipient
Q96348395	Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator
Q38763096	Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients: A Single-Center Experience in Japan.
Q39676570	Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2.
Q51830578	Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients.
Q85639530	Post-dilution hemodiafiltration with a heparin-grafted polyacrylonitrile membrane
Q36216962	Post-translational modification of Fibroblast Growth Factor 23.
Q84871638	Posterior reversible encephalopathy syndrome in systemic lupus erythematosus with anti-phospholipid antibodies treated by plasma exchange: a case report
Q77398606	Postoperative acute pulmonary thromboembolism in patients with acute necrotizing pancreatitis with special reference to apheresis therapy
Q92030133	Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy
Q97869808	Potential Limitations of Plasmapheresis in Treatment of COVID-19 Patients and How to Overcome Them?
Q73285449	Potential of rheopheresis for the treatment of acute ischemic stroke when initiated between 6 and 12 hours
Q43847054	Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy
Q34485657	Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
Q87653656	Practical approach to evaluate asymptomatic coronary artery disease in end-stage renal disease patients at the initiation of dialysis
Q33343572	Practical issues in therapeutic apheresis
Q50203698	Pre-Dialysis Neutrophil-Lymphocyte Ratio, a Novel and Strong Short-Term Predictor of All-Cause Mortality in Patients With Diabetic Nephropathy: Results From a Single-Center Study
Q92125749	Predicting 3-year mortality based on the tumor necrosis factor alpha concentration in low-flux hemodialysis patients
Q113799517	Predicting a target exercise heart rate that reflects the anaerobic threshold in nonbeta‐blocked hemodialysis patients: The Karvonen and heart rate reserve formulas
Q41158041	Prediction of Development of Critical Limb Ischemia in Hemodialysis Patients
Q91279510	Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange
Q38471069	Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
Q41649390	Predictive factors of response to leukocytapheresis therapy for ulcerative colitis
Q95417723	Preface
Q74610180	Preliminary evaluation study of a prototype hollow fiber membrane for the continuous membrane autotransfusion system
Q40485522	Preoperative and Intraoperative Factors for Early Failure of Native Arteriovenous Fistulas.
Q39700668	Preoperative dialysis for liver transplantation in methylmalonic acidemia
Q84438739	Preoperative ultrasonographic mapping of blood vessels before arteriovenous fistula construction in elderly patients with end-stage renal disease
Q47682804	Preparation of Cu2+-loaded porous chitosan particles for immunoglobulin G adsorption
Q40260061	Preparation of low density lipoprotein from large apheresis cartridges for induction of cell death in Saos2 osteoblasts
Q28257901	Present status and perspective of the development of a bioartificial kidney for chronic renal failure patients
Q33606761	Present status of apheresis technologies, part 3: adsorbent
Q77392909	Present status of apheresis technologies: Part 1. Membrane plasma separator
Q77392820	Present status of apheresis technologies: Part 2. Membrane plasma fractionator
Q33607863	Present status of apheresis technologies: part 4. Leukocyte filter
Q44986212	Present status of therapeutic apheresis in Japan: survey report. (Survey Subcommittee, Scientific Committee, Japanese Society for Apheresis).
Q98185215	Presidential Address: International Society for Apheresis: 2019-2021
Q86895732	Presidential address upon appointment to the Japanese Society for Dialysis Therapy
Q89426749	Prevalence and Severity of Postdialysis Fatigue Are Higher in Patients on Chronic Hemodialysis With Functional Disability
Q48595209	Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan
Q89426574	Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta-Analysis and Systematic Review
Q40053970	Prevalence of Earlobe Creases and Their Association With History of Cardiovascular Disease in Patients Undergoing Hemodialysis: A Cross-Sectional Study.
Q47701745	Prevalence of and Predictive Factor for Abdominal Aortic Calcification in Thai Chronic Kidney Disease Patients
Q45416925	Prevalence of hepatitis E virus infection in regular hemodialysis patients
Q38095646	Prevention and treatment of cardiovascular disease in women: the obstetric-gynecologist's point of view.
Q46556711	Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients
Q81647396	Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation
Q84585236	Priapism caused by cavernosal arterio-lacunar fistula during hemodialysis: a case report
Q46717761	Primary Amyloidosis Discovered During Pregnancy
Q48118485	Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Kidney Transplantation: A Multi-Institution Study in Japan Over 30 years.
Q50244000	Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel. 1979.
Q36473223	Principles of bound solute dialysis
Q78025174	Prions and blood: the impact on apheresis technology development
Q81647379	Problems in adapting the K/DOQI guidelines for Japanese patients with end stage renal failure
Q80707941	Proceedings of the 18th Annual Meeting of the Japanese Society for Kidney Bone Disease, February 24, 2007, Tokyo, Japan
Q92711275	Proceedings of the Inaugural Strategy Meeting for the Establishment of a Southeast Asia Regional Therapeutic Plasma Exchange Consortium for Neurological Disorders
Q53140962	Production of interleukin-10 by combining a granulocyte and monocyte adsorption carrier with ulinastatin.
Q90986944	Prognostic Impact of Early Versus Late Initiation of Renal Replacement Therapy Based on Early Warning Algorithm in Critical Care Patients With Acute Kidney Injury
Q38784065	Prognostic Value of Predialysis Indices for Technique Failure and Mortality in Peritoneal Dialysis Patients.
Q40339988	Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease
Q39854673	Prognostic study of cardiac and renal events in Japanese patients with chronic kidney disease and cardiovascular risk using myocardial perfusion SPECT: J-ACCESS 3 study design
Q83180857	Prognostic study of cardiac events in Japanese high risk hemodialysis patients using I-BMIPP-SPECT: B-SAFE study design
Q81960837	Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay
Q97879195	Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients
Q77398560	Prominent effect of immunoadsorption plasmapheresis therapy in a patient with chronic inflammatory demyelinating polyneuropathy associated with hepatitis B infection
Q90674531	Prophylactic Oral Antibiotics for Postendoscopic Peritonitis in Peritoneal Dialysis
Q44075088	Prophylactic dialysis in elderly patients undergoing coronary bypass surgery
Q87010752	Proposal for the shared decision-making process regarding initiation and continuation of maintenance hemodialysis
Q42664078	Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan
Q104503477	Prostacyclin analogue beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR Study
Q44904214	Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy
Q38702849	Protein Concentration of Refractory Ascites in Cancer Patients is Reflected by the Presence and Severity of Peritoneal and Liver Metastasis
Q83251509	Protein oxidative stress and dyslipidemia in dialysis patients
Q46877981	Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis
Q40104072	Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome
Q92365839	Psychosocial Needs of the Families With Hospitalized Organ Transplant Patients in an Educational Hospital in Iran
Q90631644	Pulmonary Hypertension Predicts Adverse Outcomes in Renal Patients: A Systematic Review and Meta-Analysis
Q74052169	Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic-DTPF System
Q47568886	Quality of Life and Depression Among Mexican Americans on Hemodialysis: A Preliminary Report
Q91035609	Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients
Q53158922	Quality of life improvements in dialysis patients receiving darbepoetin alfa.
Q46036710	Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease.
Q88129694	Questionnaire survey and serum phosphorus levels in maintenance hemodialysis patients switching lanthanum carbonate formulation from chewable tablets to granules
Q77516396	RANTES and p-selectin in peripheral blood stem cell harvest
Q40073611	RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan.
Q47796098	Radial augmentation index is related to cardiovascular risk in hemodialysis patients
Q89851464	Radial-cephalic fistula recovered with graft interposition from the brachial artery into the cephalic vein-Patient with two arteriovenous fistulas
Q90484057	Radiocephalic Fistula Recovery Using the Brachial Vein and Forearm Basilic Vein: A Case Series and Literature Review
Q45120085	Radiographic assessment of vascular calcification, aortic pulse wave velocity, ankle-brachial index and fibroblast growth factor-23 in chronic hemodialysis patients
Q87653635	Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia
Q50506523	Randomized crossover study of the efficacy and safety of sevelamer hydrochloride and lanthanum carbonate in Japanese patients undergoing hemodialysis.
Q48086607	Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients
Q85266103	Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients
Q34619667	Rapid and persistent reduction of proteinuria following plasma exchange in a case of steroid-resistant focal segmental glomerulosclerosis
Q51702583	Rapid count of microbial cells in dialysate.
Q44979383	Rapid improvement of acute pulmonary edema with angiotensin converting enzyme inhibitor under hemodialysis in a patient with renovascular disease
Q73285453	Rapid reduction of platelet numbers in thrombocytosis
Q100516592	Rapidly rising methemoglobinemia in a patient with severe COVID-19 treated successfully with red cell exchange transfusion
Q53806457	Rare Cause of Acute Kidney Injury Associated With Rhabdomyolysis: Quail Meat Consumption.
Q90577126	Rare Cause of Peritoneal Dialysis-Related Peritonitis in a Child: Microbacterium arborescens
Q53219697	Rare but Life-Threatening Complication: Delayed Common Iliac Vein Perforation by Hemodialysis Catheter.
Q82632929	Rare cause of acute hepatitis in a hemodialysis patient: herpes simplex
Q44174277	Rate of ankle-brachial index decline predicts cardiovascular mortality in hemodialysis patients
Q93046090	Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study
Q83687353	Ratio of platelet reduction is an early predictive factor for the effectiveness of leukocytapheresis for ulcerative colitis patients
Q33342209	Reactive hemophagocytic syndrome associated with thrombotic thrombocytopenic purpura during therapeutic plasma exchange.
Q48189488	Reasons for refusing kidney transplantation among chronic dialysis patients
Q84148329	Recent advances in CKD-MBD research
Q36216970	Recent advances in renal phosphate transport.
Q34024386	Recent advances of therapeutic apheresis in Guillain-Barré syndrome.
Q79663839	Recognition of intercenter differences may help develop best practice
Q48267842	Red Blood Cell Distribution Width Is Associated With All-Cause and Cardiovascular Mortality in Hemodialysis Patients.
Q77392893	Red cell apheresis: new concepts of blood component processing
Q80343339	Redefining the syndromes of thrombotic microangiopathy
Q38452218	Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study
Q40399722	Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column
Q89041090	Reflecting upon the 38th Annual Meeting of the Japanese Society for Apheresis
Q99552826	Reflections
Q45870488	Refractory acquired hemophilia: successful treatment by immunoadsorption with single-use columns.
Q57764083	Regional Citrate Anticoagulation: Beware of Recirculation Phenomenon
Q50635510	Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.
Q50862108	Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Q43288966	Regional citrate anticoagulation for intermittent predilution online hemofiltration
Q83251521	Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution
Q50522179	Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
Q42653795	Regional variation in hip fracture incidence among Japanese hemodialysis patients.
Q86895748	Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient
Q48484313	Regular exercise as a part of treatment for patients with end-stage renal disease
Q47980224	Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease
Q36988383	Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases
Q96610531	Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
Q47330030	Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients.
Q92982623	Relationship Among Coping Strategies, Quality of Life, and Anxiety and Depressive Disorders in Hemodialysis Patients
Q92414575	Relationship Among Denture Status, Remaining Teeth Number, and Malnutrition in Patients With Chronic Kidney Disease
Q87087703	Relationship Between Diastolic Dysfunction and Atherosclerosis and Vascular Calcification in Hemodialysis Patients: Diagnostic Potential of the Cardio-Ankle Vascular Index
Q91501563	Relationship Between Leptin Level, Inflammation, and Volume Status in Maintenance Hemodialysis Patients
Q50212913	Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation
Q48139940	Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program
Q90631602	Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study
Q51744413	Relationship between effluent levels of beta(2)-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution.
Q53626535	Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients.
Q87534111	Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis
Q92988558	Relationship between serum cystatin C and prognosis of nondiabetic peritoneal dialysis patients
Q80697364	Relationship between the -374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis
Q44776682	Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism
Q47211067	Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
Q88154836	Relationship between tumor necrosis factor-α release and granulocyte and monocyte adsorption to cellulose acetate beads
Q42978211	Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients
Q40882383	Relationships Between Malnutrition, Inflammation, Sleep Quality, and Restless Legs Syndrome in Hemodialysis Patients
Q42962582	Release of interleukin-1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatin
Q44433975	Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis
Q44354054	Reliability of blood pressure parameters for dry weight estimation in hemodialysis patients
Q92832408	Remembrance of Dr Akira Yamamoto
Q81337713	Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody
Q51201334	Removal Characteristics of Immunoadsorption With the Immusorba TR-350 Column Using Conventional and Selective Plasma Separators.
Q91538523	Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis
Q51714646	Removal Characteristics of Immunoglobulin G Subclasses by Conventional Plasma Exchange and Selective Plasma Exchange.
Q88748132	Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days
Q51201337	Removal Dynamics of Immunoglobulin and Fibrinogen by Conventional Plasma Exchange, Selective Plasma Exchange, and a Combination of the Two.
Q53517301	Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
Q46307217	Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock
Q73285467	Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation
Q84220910	Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis
Q43975584	Removal of endotoxin in blood by polymyxin B immobilized polystyrene-derivative fiber
Q82670514	Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column
Q88154842	Removal of toxic substances by a selective membrane plasma separator
Q51572482	Renal Improvement With Molecular-Selective Plasma Exchange in a Patient With Bence-Jones Type Multiple Myeloma.
Q31108678	Renal Replacement Therapy in Slovenia: Excerpts From 2013 Data.
Q92693955	Renal Transplant Artery Kinking Solved by Manual Manipulation in the Early Posttransplant Period
Q44560273	Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients
Q50763447	Renal replacement therapy in Slovenia: 2003 annual report.
Q30660590	Renal replacement therapy in Slovenia: excerpts from 2011 data.
Q51350192	Renal replacement therapy in cardiology wards: changing trends in a transitional country.
Q92167141	Renal transplantation in HLA sensitized patients: Traversing the immunological barrier
Q53667719	Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.
Q59745079	Reply to Letter to the Editor: Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study
Q85775076	Reply to letter to editor
Q87237415	Reply to letter to the editor
Q46288120	Reply to letter to the editor: adiponectin levels in hemodialysis patients
Q90680229	Reply to: "Risk Factors for Carotid Artery Disease and Chronic Kidney Disease: Same or Unique?" Carotid Artery Disease and Chronic Kidney Disease-Which Came the First: The Chicken or the Egg?
Q90006929	Reply to: Do Calcium-Based Phosphate Binders Accelerate or Prevent Coronary Artery Calcification in Dialysis Patients?
Q47722149	Report on Symposium Celebrating 45 Years of Chronic Hemodialysis and Transplantation in Slovenia
Q87229505	Report on the 5th Slovenian Congress of Nephrology
Q48660842	Report on the symposium celebrating the 40th anniversary of chronic dialysis and kidney transplantation in Slovenia
Q40293293	Research on Handwashing Techniques of Peritoneal Dialysis Patients From Yiwu, Southeast China
Q47710581	Residual Renal Function in Hemodialysis and Inflammation
Q50243995	Resin hemoperfusion in the treatment of drug intoxication. 1970.
Q90577420	Retained Subcutaneous Cuff After Removing Peritoneal Dialysis Catheter by Dissection: A Case Report
Q90298153	Retracted: Transforming Growth Factor Beta-1 Promotes Smooth Muscle Cell Proliferation and Migration in an Arteriovenous Fistulae: The Role of Wall Shear Stress
Q83765270	Retraction. An Australian experience with the Molecular Adsorbents Recirculating System (MARS)
Q85046137	Retraction. “Individualization of nadroparin doses inhemodialyzed patients”
Q87219867	Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease
Q48742633	Retrospective analysis of long-term lipid apheresis at a single center
Q33399210	Retrospective review of 25 cases of thrombotic thrombocytopenic purpura in Pakistan
Q91222117	Retrospective study of the adverse events of the treatment for an acute attack of neuromyelitis optica spectrum disorder
Q48930487	Reversible leukoencephalopathy syndrome associated to leukopenia in a chronic hemodialysis patient
Q36473232	Review article: clinical experience with Prometheus
Q35078676	Review of Helicobacter pylori infection and chronic renal failure
Q35764946	Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease
Q36566670	Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives
Q33700408	Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.
Q83680435	Rhabdomyolysis induced by influenza A infection: case report and review of literature
Q44835029	RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration
Q50070763	Rheopheresis for Adjuvant Treatment in Resistant Calciphylaxis
Q34775340	Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology.
Q34651421	Rheopheresis in patients with critical limb ischemia--results of an open label prospective pilot trial
Q31151097	Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial
Q34101800	Rheopheresis: rheologic, functional, and structural aspects
Q97535005	Rhizobium Radiobacter peritonitis in a peritoneal dialysis patient: Case presentation and review of the literature
Q48098751	Risk Factors for Carotid Artery Disease and Chronic Kidney Disease: Same or Unique?
Q39967622	Risk Factors for Early Failure of Arteriovenous Vascular Access Among Patients With Type 2 Diabetes Mellitus.
Q54314418	Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.
Q45260078	Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study
Q83687331	Risk factors of normal ankle-brachial index and low toe-brachial index in hemodialysis patients
Q53734691	Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis.
Q89041096	Role of Parathyroid Hormone in Regulating Transporter and Metabolizing Enzyme Function
Q91378352	Role of Plasma Exchange in the Management of Pediatric Optic Neuritis With Antibodies Against Myelin Oligodendrocyte Glycoprotein
Q48119569	Role of Plasmapheresis in the Management of Acute Kidney Injury in Patients With Multiple Myeloma: Should We Abandon It?
Q50962466	Role of Uremic Toxins on Apoptosis With Varying Periods of Hemodialysis.
Q84592768	Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study
Q46229557	Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone).
Q36216977	Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism
Q86052317	Role of different replacement fluids during extracorporeal treatment in a pig model of sepsis
Q83680375	Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120
Q37877297	Role of megalin and cubilin in the metabolism of vitamin D(3).
Q36988369	Role of megalin, a proximal tubular endocytic receptor, in calcium and phosphate homeostasis.
Q50535369	Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism.
Q43467792	Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Q37959584	Role of plasma exchange in the thyroid storm
Q85046119	Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides
Q40396107	Role of sevelamer hydrochloride in the coronary artery calcification score
Q38151985	Role of testosterone in the pathogenesis, progression, prognosis and comorbidity of men with chronic kidney disease.
Q39001581	Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia
Q83680372	Role of uremic toxins and oxidative stress in chronic kidney disease
Q36988376	Roles of organic anion transporters in the progression of chronic renal failure
Q38191278	Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world's first successful plasmapheresis
Q77398672	Safe and efficient peripheral blood stem cell collection in the smallest of children
Q50999271	Safety Aspects of Immunoadsorption in IgG Removal Using a Single-Use, Multiple-pass Protein A Immunoadsorber (LIGASORB): Clinical Investigation in Healthy Volunteers.
Q40104067	Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study
Q56589994	Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction
Q96292445	Safety and efficacy of single-needle leukocyte apheresis (LCAP) for treatment of ulcerative colitis
Q51063765	Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.
Q39793701	Safety evaluation for a cell-based immune support system in an ex vivo rat model of gram-negative sepsis
Q91760862	Safety of Direct-Acting Antiviral Therapy for Renal Function in Post-Kidney Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response: A Single-Center Study
Q84592771	Sarcomatoid carcinoma in the native kidney of a renal transplant recipient
Q33626944	Screening and analysis of adsorbents for pemphigus autoantibodies
Q40502889	Seasonal Variation in the Peritoneal Dialysis-Related Infections: A Single Center Experience in the Mediterranean
Q47978943	Seasonal Variations of Nutritional Status in Maintenance Hemodialysis Patients
Q88510037	Secondary Hyperparathyroidism and Protein-Energy Wasting in End-Stage Renal Disease
Q58590672	Secondary hyperparathyroidism: Pathogenesis and latest treatment
Q47726722	Selection of DNA Aptamer That Blocks the Fibrillogenesis of a Proteolytic Amyloidogenic Fragment of β2 m.
Q92693971	Selective C-Reactive Protein-Apheresis in Patients
Q96163644	Selective C-reactive protein (CRP) apheresis for Covid-19 patients suffering from organ damage
Q33434629	Selective Plasma Exchange for Critically Ill Patients Accompanied With Thrombocytopenia
Q47975489	Selective Plasma Exchange for the Removal of Pemphigus Autoantibodies, Fibrinogen, and Factor XIII in Pemphigus Vulgaris
Q80113964	Selective adsorption of human CD4 T cells
Q87418983	Selective plasma exchange with dialysis in patients with acute liver failure
Q46044467	Selective removal of bisphenol A from serum using molecular imprinted polymer membranes
Q77392846	Selective removal of plasma components by high-performance immunoaffinity chromatography
Q53662478	Selective renal arterial embolization in the treatment of hemodialysis patients complicated with Wünderlich syndrome: a case report.
Q47860523	Self-Care on Hemodialysis: Behaviors With the Arteriovenous Fistula.
Q58092135	Self-care Behavior of Hemodialysis Patients with Arteriovenous Fistula in China: A Multicenter, Cross-sectional Study
Q53426824	Self-care in Preserving the Vascular Network: Old Problem, New Challenge for the Medical Staff.
Q51456328	Separation of Circulating MicroRNAs Using Apheresis in Patients With Systemic Lupus Erythematosus.
Q87246714	Septic Pulmonary Embolism Caused by Internal Shunt Infection
Q100494034	Sequential Intermittent Therapeutic Plasma Exchange: A Possible Induction and Maintenance Therapy in the Management of Adult Patients with Neuromyelitis Optica Spectrum Disorder
Q93924674	Sequential plasmapheresis and intravenous immunoglobulin therapy for refractory myasthenia gravis: case report
Q77392918	Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin
Q94456908	Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
Q96221989	Seronegative Occult Hepatitis C Infection among Hemodialysis Patients: A Prevalence Study
Q86990546	Serum Cytokine Profiling of Leukocytapheresis in Pediatric Ulcerative Colitis
Q48169339	Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
Q44740069	Serum TNF-related and weak inducer of apoptosis levels in septic shock patients
Q43076030	Serum antioxidant capacity is preserved in peritoneal dialysis contrary to its robust depletion after hemodialysis and hemodiafiltration sessions
Q85046104	Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients, and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency
Q50755463	Serum creatinine and albumin decline predict the contraction of nosocomial aspiration pneumonia in patients undergoing hemodialysis.
Q54314421	Serum cystatin-C as a marker of acute kidney injury in the newborn after perinatal hypoxia/asphyxia.
Q54773676	Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
Q54636643	Serum levels of intact parathyroid hormone is a prognostic indicator of dialyzed patients: the Nishinomiya study.
Q43405909	Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients
Q46575102	Serum pro-hepcidin as an indicator of iron status in dialysis patients.
Q85560897	Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients
Q53545598	Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment.
Q88155815	Sevelamer Crystals Found in Necrotic Mucosa of a Perforated Diverticulum
Q46631801	Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients
Q54314427	Sevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in Japan.
Q80025033	Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage
Q46889871	Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels
Q88414243	Severe Glyphosate-Surfactant Intoxication Successfully Treated With Continuous Hemodiafiltration and Direct Hemoperfusion: Case Report
Q38095642	Severe hypertriglyceridemia-related acute pancreatitis
Q44471528	Severe hypertriglyceridemia-related acute pancreatitis
Q44234526	Severe hypertriglyceridemia-related acute pancreatitis: myth or reality?
Q92436016	Severe lupus nephritis in pregnancy complicated with thrombotic thrombocytopenic purpura: Successful treatment with plasma exchange and renal replacement therapy
Q50177620	Severe peritonitis in patients treated with peritoneal dialysis: a case series study
Q77398683	Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
Q50499724	Shortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysis.
Q89463825	Shortened red cell life span as a factor of anemia of mild inflammation in hemodialysis patients
Q73810090	Side-effects and complications in large-bore catheters for apheresis
Q35689904	Silver coating of dialysis catheters to reduce bacterial colonization and infection
Q89485109	Simple Formula for Predicting Drug Removal Rates During Hemodialysis
Q51563499	Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
Q54314406	Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites.
Q46044477	Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging
Q91538444	Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics
Q50475689	Skeletal muscle loss is negatively associated with single-pool Kt/V and dialysis duration in hemodialysis patients.
Q40414721	Skin Perfusion Pressure and the Prevalence of Atherothrombosis in Hemodialysis Patients
Q53352259	Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
Q87152560	Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis
Q50105684	Slovenian Renal Replacement Therapy Registry: excerpts from the 2008 Annual Report
Q51135712	Slovenian renal replacement therapy registry: excerpts from the 2006 annual report.
Q54342264	Soluble vascular endothelial-cadherin levels in patients with sepsis treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
Q91799162	Solute Clearance and Fluid Removal: Large-Dose Cyclic Tidal Peritoneal Dialysis
Q45756286	Solute removal capacity of high cut-off membrane plasma separators
Q39369437	Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure
Q36473235	Sorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure
Q52913282	Specific Accumulation of Lanthanum Carbonate in the Gastric Mucosal Histiocytes in a Dialysis Patient.
Q77398637	Specific immunoadsorbent for myasthenia gravis treatment: development of synthetic peptide designed to remove antiacetylcholine receptor antibody
Q33606767	Spin doctors: new innovations for centrifugal apheresis
Q87418984	Splenic and lung abscesses in chronic hemodialysis patient
Q63346786	Stability of Continuous Renal Replacement Therapy Solutions After Phosphate Addition: An Experimental Study
Q53195986	Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008.
Q104058696	Standard renal replacement therapy combined with hemoadsorption in the treatment of critically ill septic patients
Q45968677	Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report.
Q47735540	Star Fruit Intoxication in a Patient Undergoing Regular Hemodialysis.
Q34449802	State of percutaneous transluminal coronary artery angioplasty and effectiveness of low-density lipoprotein apheresis
Q35837148	State of the art of low-density lipoprotein apheresis in the year 2003.
Q78064893	State of the art of therapeutic apheresis in Europe
Q79663844	Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan
Q73641930	Status of platelet collection and platelet transfusion
Q45936658	Strategies for the creation and maintenance of reconstructed arteriovenous fistulas using the forearm basilic vein.
Q77392928	Strategy of leukocyte filtration for immunomodulation: development of stainless steel leukocyte filter
Q36216956	Structural and biochemical properties of fibroblast growth factor 23.
Q44552976	Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis
Q41971272	Study of electrical power facilities and measures for planned outages in Japanese hemodialysis clinics after the Great East Japan Earthquake.
Q50245026	Study of filtration characteristics of EVAL secondary filters in plasma diseases. 1985.
Q44904203	Study of plasma exchange for liver failure: beneficial and harmful effects.
Q81647399	Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis
Q57217888	Study of prolonged administration of lanthanum carbonate in dialysis patients
Q79346600	Study of safe usage of high-flow three-way stopcocks in a blood circuit
Q90604041	Subcutaneous Nodule at the Sacral Region as a Rare Skin Manifestation of Dialysis-Related Amyloidosis
Q81870394	Subcutaneous compared with intravenous epoetin treatment in patients on hemodialysis: one center study
Q39676576	Subendocardial Viability Ratio Is Impaired in Highly Proteinuric Chronic Kidney Disease Patients With Low Estimated Glomerular Filtration Rate.
Q97588333	Success of rheopheresis to treat digital hypoperfusion ischemic syndrome
Q40503602	Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases
Q89248116	Successful Treatment of Atypical Hemolytic Uremic Syndrome With Therapeutic Plasma Exchange in a 3.8-kg Neonate
Q89171395	Successful Treatment of C1q Nephropathy by Low-Density Lipoprotein Apheresis
Q48301946	Successful Treatment of Enterohemorrhagic Escherichia coli-Induced Acute Encephalopathy and Hemolytic-Uremic Syndrome With Polymyxin-B Direct Hemoperfusion
Q90657036	Successful Treatment of Tuberculosis-Associated Hypercalcemia With Denosumab in a Patient With Acute Kidney Injury
Q28180448	Successful delivery in a pregnant woman with lupus anticoagulant positive systemic lupus erythematosus treated with double filtration plasmapheresis
Q84149179	Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns
Q83680442	Successful peritoneal lavage therapy for prevention of encapsulating peritoneal sclerosis: a case report
Q84149174	Successful permanent catheter implantation after percutaneous transluminal angioplasty to the right subclavian and inominate vein stenosis in a hemodialysis patient
Q48221080	Successful plasmapheresis in the not-so-benign Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody
Q36697828	Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages.
Q92167644	Successful treatment of Hashimoto encephalopathy with therapeutic plasma exchange
Q54296181	Successful treatment of enterohemorrhagic Escherichia coli O111-induced acute encephalopathy and hemolytic-uremic syndrome with plasma diafiltration.
Q38127948	Successful treatment of severe hantavirus nephritis with corticosteroids: a case report and literature review.
Q91424775	Successful treatment of tetanus with magnesium in a dialysis patient
Q87418976	Successful treatment of three cases of generalized pustular psoriasis with granulocyte and monocyte adsorption apheresis
Q51702168	Successful treatment of ulcerative colitis with leukocytapheresis using non-woven polyester filter.
Q83680448	Successful treatment with cyclosporine of thrombotic thrombocytopenic purpura refractory to corticosteroids and plasma exchange
Q44137828	Successful use of tocilizumab in a case of multicentric Castleman's disease and end-stage renal disease
Q34316357	Summary from the International Society for Apheresis 3rd World Congress Taipei, Taiwan, January 11-14, 2001.
Q93146629	Summary of the Second Congress of the International Society for Apheresis-European Group and the Austrian Apheresis Association
Q50054296	Super High-Flux Continuous Venovenous Hemodialysis Using Regional Citrate Anticoagulation: Long-Term Stability of Middle Molecule Clearance.
Q94477196	Super High-Flux Hemodialysis Provides Comparable Effectiveness with High-Volume Post-dilution Online Hemodiafiltration in Removing Protein-bound and Middle-molecule Uremic Toxins: A Prospective Cross-over Randomized Controlled Trial
Q87488780	Superior Vena Cava Obstruction in Hemodialysis Patients: Symptoms, Clinical Presentation and Outcomes Compared to Other Etiologies
Q40568201	Superlite Plasma Collection System
Q96292471	Suppression of inflammation during cell-free concentrated ascites reinfusion therapy (CART) using a blood purification device
Q81647410	Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis
Q30632075	Surface treated catheters with ion beam based process for blood access
Q96768427	Surgical Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism resistant to calcimimetic treatment: a Retrospective Single-center Cohort Study
Q39032220	Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis Patients
Q50769241	Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease.
Q51429473	Surgical salvage of thrombosed arteriovenous fistulas and grafts.
Q43941162	Surgical salvage of thrombosed native arteriovenous fistulas for hemodialysis by interventional nephrologists
Q44706909	Surgical thrombectomy of thrombosed arteriovenous grafts by interventional nephrologists
Q51242307	Surveillance of infection control procedures in dialysis units in Japan: a preliminary study.
Q46447700	Survey of depression by Beck Depression Inventory in uremic patients undergoing hemodialysis and hemodiafiltration
Q43288972	Survey of renal transplantation in Slovenia
Q86052299	Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan
Q91294849	Survival comparison between superficialization of the brachial artery and tunneled central venous catheter placement in hemodialysis patients with heart failure: a retrospective study
Q96224784	Sustained low-efficiency dialysis with regional citrate anticoagulation for patients with liver impairment in intensive care unit: a single center experience
Q89149244	Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification
Q46436552	Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient
Q46436569	Synergistic cytotoxicity of acidity and 3,4-Dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid
Q83765249	Systematic evaluation of vascular access by color-Doppler ultrasound decreased the incidence of emergent vascular access intervention therapy and X-ray exposure time: a single-center observational study
Q77455055	Tandem plasmapheresis and hemodialysis
Q46044482	Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c).
Q48366227	Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis.
Q77392877	Technical aspect of Therapeutic Apheresis in the year of 1997
Q39676587	Temporary Catheters as a Permanent Vascular Access in Very Elderly Hemodialysis Patients: Frequency of Complications and Interventions.
Q36168633	Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients
Q33979770	Temporary vascular access for extracorporeal therapies
Q50535364	Tertiary hyperparathyroidism resistant to cinacalcet treatment.
Q51316822	The 36(th) Annual Meeting of the Japanese Society for Apheresis.
Q92832424	The 39th Annual Meeting of the Japanese Society for Apheresis
Q73883852	The 3rd World Congress of the International Society for Apheresis. Taipei, Taiwan. January 11-14, 2001. Proceedings and abstracts
Q96221822	The Application Of Plasmapheresis For Covid-19 Patients
Q104751334	The Assessment of the Accuracy of an Intermittent-scanning Continuous Glucose Monitoring Device in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis (AIDT2H) Study
Q91889240	The Challenge of Haemodialysis: A Patient with Glioblastoma Cerebri, Cerebral Edema and Haemorrhagic Stroke
Q92080473	The Effect of Aquaporin 1 on mice's peritoneal mesothelial cells after a long-term peritoneal dialysis
Q90298118	The Effectiveness of Scoring Systems in the Prediction of Diagnosis-Based Mortality
Q87371484	The Forgotten Issue of Glucose Delivery to Diabetes Patients in On-Line Hemodiafiltration
Q35187607	The HELP system for the treatment of atherothrombotic disorders: a review
Q87083724	The ISFA wishes to acknowledge the following 2015 Corporate Sponsors
Q88123813	The ISFA wishes to acknowledge the following 2016 Corporate Sponsors
Q89412529	The ISFA wishes to acknowledge the following 2016 Corporate Sponsors
Q89940521	The ISFA wishes to acknowledge the following 2016 Corporate Sponsors
Q89486438	The ISFA wishes to acknowledge the following 2017 Corporate Sponsors
Q57062821	The ISFA wishes to acknowledge the following 2018 Corporate Sponsors
Q87700148	The ISFA wishes to acknowledge the following 2018 Corporate Sponsors
Q90283081	The ISFA wishes to acknowledge the following 2018 Corporate Sponsors
Q98198542	The Impact Of Preoperative Arterial And Venous Diameter On Achievement Of The Adequate Blood Flow In Arteriovenous Fistula For Hemodialysis
Q73297350	The North American experience with photopheresis
Q33541684	The North American experience with photopheresis.
Q47820941	The Predictive Value of Platelet/Lymphocyte Ratio in Hemodialysis Patients With Erythropoietin Resistance.
Q92007458	The Relationship Between Pai-1 Gene Alterations and Fibrosis in Peritoneal Dialysis Patients
Q100516668	The Severity of COVID-19 in End-Stage Kidney Disease Patients on Chronic Dialysis
Q78025196	The beneficial effects of lymphocytapheresis for treatment of nephrotic syndrome
Q74581814	The blood purification technologies in the twenty-first century
Q101410413	The carbon footprint of a haemodialysis unit in Morocco
Q73810063	The challenge of evidence-based medicine for apheresis
Q75227154	The change in renal replacement therapy on acute renal failure in a general intensive care unit in a university hospital and its clinical efficacy: a Japanese experience
Q57222928	The current state of chronic dialysis treatment in Japan (as of December 31, 2000)
Q50243996	The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney. 1970.
Q33607842	The development of recombinant human serum albumin
Q79832165	The dose of nafamostat mesilate during plasma exchange with continuous hemodiafiltration in the series-parallel circuit
Q100480305	The durability of tunneled catheters in children is associated with catheter tip depth. A single center report
Q35187626	The effect of apheresis on adhesion molecules
Q44952494	The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection.
Q82925006	The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock
Q44549736	The effect of membrane differential filtration on the colloid osmotic pressure in patients with age-related macular degeneration: significance to visual function?
Q50175750	The effect of patient age and other factors on the maintenance of permanent hemodialysis vascular access
Q77398620	The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients
Q78025184	The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study
Q44884393	The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (Plasmat Futura) in comparison with the currently used system (Plasmat Secura).
Q77392715	The efficacy of plasmapheresis or leukocytapheresis for articular and extraarticular manifestations of rheumatoid arthritis
Q33328678	The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports
Q43975601	The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange
Q77392863	The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone
Q43076026	The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis
Q96954101	The holistic vision of the patient with chronic kidney disease in an universalistic health care system
Q99713962	The impact of malnutrition on health-related quality of life in patients on maintenance hemodialysis
Q46436532	The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites
Q82925080	The influence of uremic serum on interleukin-1beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells
Q40310344	The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan
Q52041827	The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis.
Q100516635	The novel coronavirus disease in patients with end-stage kidney disease
Q84438756	The paper published by Drs Lentz and Kumar in the December 2008 issue
Q97870191	The physiological role of plasma and its components and the clinical implications of different methods of apheresis. A narrative review
Q44256127	The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach
Q34775359	The present status and the recent development of the treatment for inflammatory bowel diseases: desirable effect of extracorporeal immunomodulation.
Q42774519	The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.
Q33606755	The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia
Q48374184	The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience
Q80113946	The role of apheresis therapy in living donor liver transplantation
Q34557092	The role of blood component removal in essential and reactive thrombocytosis
Q74052182	The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus
Q77392884	The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia
Q77295746	The role of low-density lipoprotein apheresis in the treatment of hypercholesterolemia and arteriosclerosis
Q40568409	The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus
Q34557078	The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease.
Q73883844	The role of rheology in hemapheresis
Q33541681	The role of therapeutic apheresis in the treatment of cancer: a review.
Q80343355	The salvage of graft occlusion in a maintenace hemodialysis patient with tuberous sclerosis by percutaneous transluminal angioplasty using intravascular ultrasound: case report
Q73726225	The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification
Q38516956	The series-parallel circuit in the treatment of fulminant hepatitis
Q54015821	The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
Q74278304	The six year experience of plasmapheresis in patients with myasthenia gravis
Q77392834	The steroid-sparing effect of long-term plasmapheresis in pemphigus: an update
Q73814736	The structure and characteristics of polypropylene hollow fiber membrane plasma separator
Q35199884	The use of apheresis in immune renal disorders
Q77392701	Theoretic opinion and future treatment of amyloidosis
Q33606737	Theoretical background of effect mechanism by extracorporeal immunomodulation
Q85046098	Theoretical basis of pathogenic substance removal during plasmapheresis
Q91718115	Therapeutic Apheresis (TA) in ABO-incompatible kidney and liver transplantation: A single center experience of 50 patients
Q90045833	Therapeutic Apheresis and Dialysis Upcoming Meetings April 2020
Q92369016	Therapeutic Apheresis and Dialysis Upcoming Meetings February 2020
Q87297426	Therapeutic Apheresis and Dialysis: 20(th) Year of Publication
Q38955520	Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin
Q39025553	Therapeutic Apheresis in Immunologic Renal and Neurological Diseases
Q38895910	Therapeutic Apheresis in Pregnancy: Three Differential Indications With Positive Maternal and Fetal Outcome
Q86531365	Therapeutic Apheresis: Why?
Q90227033	Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience
Q48098936	Therapeutic Plasma Exchange Strategy in Complement-Mediated Diseases: An Overview
Q99560142	Therapeutic Plasma Exchange Therapy Support for Critical COVID-19: A Case Report
Q90953531	Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population
Q92611037	Therapeutic Plasma Exchange in Tehran Between 2011 and 2014
Q48177702	Therapeutic Thrombocytapheresis for Symptomatic Thrombocytosis in Hemato-Oncology Patients.
Q74052160	Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations
Q33333241	Therapeutic apheresis for cancer related hemolytic uremic syndrome
Q74278260	Therapeutic apheresis for neurological diseases
Q77398602	Therapeutic apheresis for renal diseases
Q33328181	Therapeutic apheresis for renal disorders.
Q34316334	Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
Q79771914	Therapeutic apheresis in Japan
Q77790053	Therapeutic apheresis in Russia: is it just isolation or original development?
Q40589858	Therapeutic apheresis in Taiwan
Q77392896	Therapeutic apheresis in malignancy
Q34024379	Therapeutic apheresis in multiple sclerosis and other central nervous system disorders.
Q33916815	Therapeutic apheresis in myasthenia gravis
Q73297325	Therapeutic apheresis in myasthenia gravis patients: a six year follow-up
Q33643213	Therapeutic apheresis in neurological disorders
Q74610148	Therapeutic apheresis in the United States: current indications and directions
Q33393870	Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects
Q35689910	Therapeutic apheresis therapy for ABO-incompatible renal transplantations
Q36341821	Therapeutic apheresis--state of the art in the year 2005.
Q77748423	Therapeutic apheresis: current perspectives
Q73641917	Therapeutic apheresis: further development in the new century
Q38246628	Therapeutic applications of mesothelial cell sheets
Q50245041	Therapeutic cryogel removal in autoimmune disease: what is cryogel. 1982.
Q40815186	Therapeutic cytapheresis for inflammatory bowel disease
Q50245071	Therapeutic membrane plasmapheresis. 1981.
Q78064944	Therapeutic plasma exchange and cyclosporine in the treatment of systemic lupus erythematosus
Q51708003	Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
Q46575113	Therapeutic plasma exchange for acute hyperlipidemic pancreatitis: a case series
Q33606753	Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis
Q87534641	Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated Syndrome
Q78064973	Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation
Q51562026	Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
Q33349512	Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience.
Q92546352	Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications
Q34485642	Therapeutic plasma exchange in the intensive care setting.
Q73285445	Therapeutic plasma exchange in treatment of adrenoleukodystrophy
Q35199896	Therapeutic plasma exchange: an underutilized therapeutic modality?
Q39705729	Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia
Q38095647	Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease
Q77398658	Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus
Q36566674	Therapeutic strategies for secondary hyperparathyroidism in dialysis patients.
Q46631784	Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation
Q96610609	Therapeutically-Rational Exchange (T-REX) of Gerbich-Negative Red Blood Cells Can be Evaluated in Papua New Guinea as "a Rescue Adjunct" for Patients with Plasmodium falciparum Malaria
Q43547404	Three cases of C-ANCA-positive vasculitis treated with immunoadsorption: possible benefit in early treatment
Q53052540	Three cases of emphysematous cystitis in end-stage renal disease patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
Q34646396	Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation.
Q51249822	Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.
Q80343342	Thrombotic thrombocytopenia purpura: an update
Q33331021	Thrombotic thrombocytopenic purpura in a patient with rheumatoid arthritis treated by plasmapheresis
Q33376612	Thrombotic thrombocytopenic purpura-like thrombocytopenia closely related to uremia: report of two cases
Q33361703	Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow
Q40529207	Thyroid storm-induced multiple organ failure relieved quickly by plasma exchange therapy
Q44235195	Time-course of iodine elimination by hemodialysis in patients with renal failure after angiography.
Q86938027	Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
Q38111847	Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.
Q90656548	Timing of Dialysis Initiation and Mortality Risk in Chronic Kidney Disease: A Meta-Analysis
Q43642114	Timing of continuous renal replacement therapy initiation in septic shock and acute kidney injury
Q77398537	Timing of effective natural killer cell collection in cancer patients after high dose chemotherapy, compared to peripheral blood stem cell collection
Q57623267	To Treat or Not To Treat Renal Anemia of Chronic Kidney Disease Patients?
Q51280039	Toll-Like Receptors in the Progression of Autosomal Dominant Polycystic Kidney Disease.
Q51197552	Total Phosphate Elimination is Negatively Associated With Increased Serum Fibroblast Growth Factor 23 Levels in Patients who Undergo Peritoneal Dialysis.
Q37599957	Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in Japan
Q40112499	Transition From Heparin to Citrate Anticoagulation for Continuous Renal Replacement Therapy: Safety, Efficiency, and Cost.
Q50592282	Transitional B Cells Predominantly Reconstituted After a Desensitization Therapy Using Rituximab Before Kidney Transplantation.
Q51702173	Transluminal removal of an embolized venous catheter fragment with simple means: a case report.
Q103008497	Transposition of brachiobasilic arteriovenous fistulas: One-stage or Two-stage technique and factors affecting the early maturation
Q55894925	Treatment of Amanita Phalloides Poisoning: I. Retrospective Evaluation of Plasmapheresis in 21 Patients
Q42102593	Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.
Q84220863	Treatment of anemia with epoetin in kidney transplant recipients
Q78064997	Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report
Q34316346	Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
Q31154170	Treatment of autoimmune diseases in mice by a new method for allogeneic bone marrow transplantation
Q77392841	Treatment of experimental allergic encephalomyelitis by selective removal of CD4+ T cells
Q80697345	Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate
Q43288965	Treatment of hyperlipidemic acute pancreatitis with plasma exchange: a single-center experience
Q51131048	Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptoms.
Q43638956	Treatment of multiple organ failure through sepsis by surgery and blood purification
Q80994869	Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis
Q54369969	Treatment of severe genetic dyslipidemia: where are we going?
Q42978230	Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis
Q77516387	Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: a Phase 1 clinical trial
Q46631789	Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors
Q83680396	Treatment with pravastatin attenuates oxidative stress and protects osteoblast cell viability from indoxyl sulfate
Q48262562	Treatment with steroids and double filtration plasmapheresis for a case of anti-GQ1b antibody-positive Bickerstaff's encephalitis
Q39243747	Triceps Skinfold Thickness Is Associated With Lumbar Bone Mineral Density in Peritoneal Dialysis Patients.
Q44904219	Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome
Q92108358	Tuberculosis spondylitis in patients on hemodialysis: clinical features, risk factors and outcomes in 12 patients
Q83680387	Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification
Q92511580	Tunneled dialysis catheter exchange through fibrin sheath crevice vs in-situ catheter exchange for the treatment of catheter dysfunction
Q33360891	Twice daily plasma exchange in refractory thrombotic thrombocytopenic purpura
Q85997692	Twice-monthly administration of a lower dose of epoetin beta pegol can maintain adequate hemoglobin levels in hemodialysis patients
Q53551519	Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.
Q47940708	Two case reports of successful therapeutic erythrocytapheresis as an adjunctive therapy in severe falciparum malaria
Q53397294	Two cases of postoperative thrombotic thrombocytopenic purpura.
Q39419029	Two cases of refractory endocrine ophthalmopathy successfully treated with extracorporeal immunoadsorption
Q77392724	Two patients with acute Guillain-Barré syndrome treated with different apheresis methods
Q50105673	Two single-lumen noncuffed catheters in the jugular vein as long-term vascular access: a preliminary report
Q43811094	Two transfusion-related acute lung injury episodes in a recipient of AB plasma from multiparous donors
Q84538250	Two variable sodium profiles and adverse effects during hemodialysis: a randomized crossover study
Q47693490	Two-Stage Basilic Vein Transposition: Second Stage Results
Q85560865	Type II diabetes mellitus is a risk factor for heart failure in pre-dialysis patients
Q48112913	Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al.
Q94558982	Ultrafiltration volume by once-weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis
Q85560868	Ultrasonographic assessment of polytetrafluoroethylene upper extremity arteriovenous hemodialysis access: a retrospective analysis of 31 cases
Q51554608	Ultrasonographic detection of thyroid nodules in hemodialysis patients in Japan.
Q54572137	Ultrasound evaluation of the effects of leukocytapheresis on rheumatoid arthritis.
Q89494404	Ultrasound-Guided Superficialization of an Arteriovenous Fistula by Minimally Invasive Liposuction Technique
Q38982404	Umbilical Hernia in Peritoneal Dialysis Patients: Surgical Treatment and Risk Factors
Q78493231	Understanding immunological effects on patients by therapeutic apheresis
Q53039139	Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Q48150991	Unusual Cause of Peritonitis in Peritoneal Dialysis: Streptococcus vestibularis
Q97537934	Upcoming Meetings Therapeutic Apheresis and Dialysis August 2020
Q89940525	Upcoming Meetings Therapeutic Apheresis and Dialysis February 2017
Q87700145	Upcoming Meetings Therapeutic Apheresis and Dialysis February 2018
Q57062820	Upcoming Meetings Therapeutic Apheresis and Dialysis October 2018
Q101566172	Upcoming Meetings Therapeutic Apheresis and Dialysis Upcoming Meetings December 2020
Q48261363	Update on Postdialysis Rebound by a New Technology in Hemodialysis.
Q45415822	Updates in apheresis and atherosclerotic research
Q84166956	Upper limb disability in hemodialysis patients: evaluation of contributing factors aside from amyloidosis
Q54602058	Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferation.
Q37855988	Uremic toxins and oral adsorbents
Q40414828	Ursodeoxycholic Acid for Treatment of Enlarged Polycystic Liver
Q100380058	Use of Angiotensin Converting Enzyme Inhibitors in Patients Receiving Therapeutic Plasma Exchange with Centrifuge-based Apheresis System
Q46211690	Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis
Q92988343	Use of double filtration plasmapheresis for the treatment of acquired thrombocytopenic thrombotic purpura
Q40758867	Use of human preconditioned phagocytes for extracorporeal immune support: introduction of a concept
Q45001450	Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury
Q47834762	Use of the Fractional Excretion of Urea in an Azotemic Nonoliguric State: Type 1 Cardiorenal Syndrome
Q41661620	Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients
Q39908468	Utility of Ultrasonography of the Median Nerve With a High-Frequency Probe for the Diagnosis of Dialysis-Related Carpal Tunnel Syndrome
Q88931696	Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses
Q104103993	Vadadustat for Anemia in Chronic Kidney Disease on Peritoneal Dialysis: A Phase 3 Open-Label Study in Japan
Q45325138	Vaginal leakage of peritoneal dialysate in a peritoneal dialysis patient
Q48211976	Validating the absolute reliability of a fat free mass estimate equation in hemodialysis patients using near-infrared spectroscopy
Q48273061	Validation of Modelflow Estimates of Cardiac Output in Hemodialysis Patients.
Q48066057	Validity of a checklist for hemodialysis patients based on the International Classification Of Functioning, Disability and Health
Q84220904	Value of β2-microglobulin in the serum of healthy subjects older than 40 years
Q48147927	Vancomycin-Resistant Staphylococcus hemolyticus Bacteremia Treated Successfully by Intravenous Daptomycin and Catheter Removal in a Hemodialysis Patient
Q87686569	Vascular Access Effects on Motor Performance and Anthropometric Indices of Upper Extremities
Q92184578	Vascular Access in Patients Treated with Continuous Renal Replacement Therapy: A Report from a Single Center in China
Q35199904	Vascular access for apheresis in intensive care patients.
Q36168616	Vascular access for hemodialysis: arteriovenous fistula
Q73810054	Vascular access in apheresis
Q51702181	Vascular access in apheresis: part II.
Q44959870	Vascular access in children on chronic hemodialysis: a Slovenian experience
Q43288959	Vascular access in patients treated with chronic hemodialysis for 30 years or more
Q87653676	Vascular access puncture under ultrasound guidance
Q84438744	Vascular access recirculation in hemodialysis patients with two noncuffed, single-lumen, jugular catheters in the same jugular vein
Q92988403	Vascular access-related mortality in hemodialysis patients during and after hospitalization
Q82632887	Vascular calcification in patients with chronic kidney disease
Q81960823	Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column
Q42978237	Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels
Q84438712	Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients
Q83680404	Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism
Q89268976	Vitamin K Antagonist Therapy Is a Risk Factor for Ulcer Development and Death Among Dialyzed Patients
Q34557125	Volunteer donor apheresis.
Q45005671	Waardenburg syndrome with familial unilateral renal agenesis: a new syndrome variant?
Q90226306	Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report
Q47175808	What are the lowest doses of low molecular weight heparin for effective and safe hemodialysis in different subgroups of patients?
Q93186054	Which Type of Temporary Hemodialysis Catheter Should Be Used for the Right Internal Jugular Vein? Prospective Observational Study of Straight vs. Precurved Catheters
Q39811599	White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients
Q53112915	Why an apheresis center should offer more than one lipoprotein apheresis method.
Q90824963	With reasonable doubt: Plasma exchange in PEXIVAS
Q45968679	Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
Q39250061	Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis
Q83308811	rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors

P6981	ACNP journal ID	2470326
		2108691
		2108692
P8375	Crossref journal ID	3736
		15516
P1250	Danish Bibliometric Research Indicator (BFI) SNO/CNO	17336
P356	DOI	10.1111/(ISSN)1744-9987
P1058	ERA Journal ID	36374
P236	ISSN	1091-6660
		1526-0968
		1744-9979
		1744-9987
P1277	JUFO ID	68403
P1055	NLM Unique ID	9706703
		101181252
P10283	OpenAlex ID	S185416529
P3181	OpenCitations bibliographic resource ID	245664
		159515
P7461	Publons journals/conferences ID	6050
P1156	Scopus source ID	20517
		110245

P1240	Danish Bibliometric Research Indicator level	1
P8875	indexed in bibliographic review	Scopus	Q371467
		Science Citation Index Expanded	Q104047209
P123	publisher	Wiley-Blackwell	Q767319
P1476	title	Therapeutic Apheresis and Dialysis

Therapeutic Apheresis and Dialysis

journal

Reverse relations